Title,Authors,Platform,Cited_url,Cited_count,Year
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial,"DW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, ...","The Lancet 385 (9967), 517-528",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9416039584394878400,1481,2015
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1,"PF Robbins, RA Morgan, SA Feldman, JC Yang, RM Sherry, ME Dudley, ...","Journal of Clinical Oncology 29 (7), 917",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10893578580847412259,1274,2011
"Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy","CL Mackall, TA Fleisher, MR Brown, MP Andrich, CC Chen, IM Feuerstein, ...","New England Journal of Medicine 332 (3), 143-149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14265636504535220939,1119,1995
Current concepts in the diagnosis and management of cytokine release syndrome,"DW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ...","Blood 124 (2), 188-195",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17492543877755869613,846,2014
Interleukin-7: from bench to clinic,"TJ Fry, CL Mackall","Blood, The Journal of the American Society of Hematology 99 (11), 3892-3904",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16525622805870747297,556,2002
The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance,"TJ Fry, CL Mackall","The Journal of Immunology 174 (11), 6571-6576",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5654642065098241942,553,2005
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors,"AH Long, WM Haso, JF Shern, KM Wanhainen, M Murgai, M Ingaramo, ...","Nature medicine 21 (6), 581",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6350647089302207335,488,2015
A potential role for interleukin-7 in T-cell homeostasis,"TJ Fry, E Connick, J Falloon, MM Lederman, DJ Liewehr, J Spritzler, ...","Blood 97 (10), 2983-2990",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11997366379481497776,455,2001
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets,"C Sportès, FT Hakim, SA Memon, H Zhang, KS Chua, MR Brown, ...","Journal of Experimental Medicine 205 (7), 1701-1714",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1983384333575166215,437,2008
Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing.,"CL Mackall, CV Bare, LA Granger, SO Sharrow, JA Titus, RE Gress","The Journal of Immunology 156 (12), 4609-4616",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12552617100672685876,432,1996
Harnessing the biology of IL-7 for therapeutic application,"CL Mackall, TJ Fry, RE Gress","Nature Reviews Immunology 11 (5), 330",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3578129083987352850,424,2011
Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy,"E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ...","Cancer discovery 5 (12), 1282-1295",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3226437564403673548,415,2015
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells,"SA Rosenberg, C Sportès, M Ahmadzadeh, TJ Fry, LT Ngo, SL Schwarz, ...","Journal of immunotherapy (Hagerstown, Md.: 1997) 29 (3), 313",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7812660771288160558,398,2006
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4,"H Zhang, KS Chua, M Guimond, V Kapoor, MV Brown, TA Fleisher, ...","Nature medicine 11 (11), 1238",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11906544323755717913,392,2005
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy,"CL Mackall, TA Fleisher, MR Brown, MP Andrich, CC Chen, IM Feuerstein, ...","Blood 89 (10), 3700-3707",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6325052719159543996,378,1997
Lymphocyte depletion during treatment with intensive chemotherapy for cancer,"CL Mackall, TA Fleisher, MR Brown, IT Magrath, AT Shad, ME Horowitz, ...","Blood 84 (7), 2221-2228",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13625050900634597745,376,1994
Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia,"W Haso, DW Lee, NN Shah, M Stetler-Stevenson, CM Yuan, IH Pastan, ...","Blood 121 (7), 1165-1174",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2074092503565496516,351,2013
Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells,"FT Hakim, R Cepeda, S Kaimei, CL Mackall, N McAtee, JA Zujewski, ...","Blood 90 (9), 3789-3798",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5957570748612936851,348,1997
"Age-dependent incidence, time course, and consequences of thymic renewal in adults","FT Hakim, SA Memon, R Cepeda, EC Jones, CK Chow, C Kasten-Sportes, ...","The Journal of clinical investigation 115 (4), 930-939",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=556521225125185517,335,2005
T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny,"CL Mackall, L Granger, MA Sheard, R Cepeda, RE Gress","Blood 82 (8), 2585-2594",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13206705928481129820,335,1993
IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation,"CL Mackall, TJ Fry, C Bare, P Morgan, A Galbraith, RE Gress","Blood 97 (5), 1491-1497",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7743568361907068430,332,2001
Interleukin-7: master regulator of peripheral T-cell homeostasis?,"TJ Fry, CL Mackall","Trends in immunology 22 (10), 564-571",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13733141643260387707,315,2001
Immune dysregulation in TGF-beta 1-deficient mice.,"M Christ, NL McCartney-Francis, AB Kulkarni, JM Ward, DE Mizel, ...","The Journal of Immunology 153 (5), 1936-1946",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3858828980421609746,301,1994
Thymic aging and T‐cell regeneration,"CL Mackall, RE Gress","Immunological reviews 160 (1), 91-102",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16695721381851971798,287,1997
Neonates support lymphopenia-induced proliferation,"B Min, R McHugh, GD Sempowski, C Mackall, G Foucras, WE Paul","Immunity 18 (1), 131-140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9349872489630661517,279,2003
Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy,"SL Highfill, Y Cui, AJ Giles, JP Smith, H Zhang, E Morse, RN Kaplan, ...","Science translational medicine 6 (237), 237ra67-237ra67",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11554702566357862374,278,2014
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy,"TJ Fry, NN Shah, RJ Orentas, M Stetler-Stevenson, CM Yuan, ...","Nature medicine 24 (1), 20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12685461351438113616,274,2018
IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates,"TJ Fry, M Moniuszko, S Creekmore, SJ Donohue, DC Douek, S Giardina, ...","Blood 101 (6), 2294-2299",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3401594228841432561,270,2003
T-cell regeneration: all repertoires are not created equal,"CL Mackall, FT Hakim, RE Gress","Immunology today 18 (5), 245-251",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16763510790849874406,263,1997
Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8,"F Melchionda, TJ Fry, MJ Milliron, MA McKirdy, Y Tagaya, CL Mackall","The Journal of clinical investigation 115 (5), 1177-1187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15303840628612935456,252,2005
Pathways of T‐cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy,"CL Mackall, RE Gress","Immunological reviews 157 (1), 61-72",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16641680795931046902,248,1997
A role for thymic stromal lymphopoietin in CD4+ T cell development,"A Al-Shami, R Spolski, J Kelly, T Fry, PL Schwartzberg, A Pandey, ...","Journal of Experimental Medicine 200 (2), 159-168",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6342800950667093776,245,2004
T‐cell immunodeficiency following cytotoxic antineoplastic therapy: a review,CL Mackall,"Stem cells 18 (1), 10-18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18087477061259102626,240,2000
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.,"JJ Letterio, AG Geiser, AB Kulkarni, H Dang, L Kong, T Nakabayashi, ...","The Journal of clinical investigation 98 (9), 2109-2119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15974841937162994208,234,1996
Restoration of T-cell homeostasis after T-cell depletion,"CL Mackall, FT Hakim, RE Gress","Seminars in immunology 9 (6), 339-346",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3997583837060271130,224,1997
Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4,"M Guimond, RG Veenstra, DJ Grindler, H Zhang, Y Cui, RD Murphy, ...","Nature immunology 10 (2), 149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11598895549653651861,212,2009
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.,"AB Kulkarni, JM Ward, L Yaswen, CL Mackall, SR Bauer, CG Huh, ...","The American journal of pathology 146 (1), 264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2475609911311505720,208,1995
Autoimmunity during lymphopenia: a two-hit model,"T Krupica Jr, TJ Fry, CL Mackall","Clinical immunology 120 (2), 121-128",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=269635347547588209,186,2006
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy,"H Zhang, KM Snyder, MM Suhoski, MV Maus, V Kapoor, CH June, ...","The Journal of Immunology 179 (7), 4910-4918",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10804480038622596783,175,2007
Interleukin-7 restores immunity in athymic T-cell–depleted hosts,"TJ Fry, BL Christensen, KL Komschlies, RE Gress, CL Mackall","Blood 97 (6), 1525-1533",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=570885918017477936,173,2001
Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age‐associated thymic involution,"CL Mackall, JA Punt, P Morgan, AG Farr, RE Gress","European journal of immunology 28 (6), 1886-1893",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16579842304137337060,171,1998
Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression,"K Beppu, J Jaboine, MS Merchant, CL Mackall, CJ Thiele","Journal of the National Cancer Institute 96 (1), 46-55",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9741442591032341211,164,2004
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy,"C Sportès, RR Babb, MC Krumlauf, FT Hakim, SM Steinberg, CK Chow, ...","Clinical Cancer Research 16 (2), 727-735",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13951573845544832924,158,2010
Interleukin 7 worsens graft-versus-host disease,"ML Sinha, TJ Fry, DH Fowler, G Miller, CL Mackall","Blood 100 (7), 2642-2649",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2820222455358228647,151,2002
Pilot trial of tumor‐specific peptide vaccination and continuous infusion interleukin‐2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter …,"R Dagher, LM Long, EJ Read, SF Leitman, CS Carter, M Tsokos, ...",Medical and Pediatric Oncology: The Official Journal of SIOP—International …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10104179905607003275,149,2002
Therapy-induced alterations in host defense in children receiving therapy for cancer,"T Lehrnbecher, C Foster, N Vázquez, CL Mackall, SJ Chanock","Journal of pediatric hematology/oncology 19 (5), 399-417",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11383019414163337360,146,1997
Induction of caspase 8 by interferon γ renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a …,"X Yang, MS Merchant, ME Romero, M Tsokos, LH Wexler, U Kontny, ...","Cancer research 63 (5), 1122-1129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13275709187694872548,139,2003
A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice.,"TA Borkowski, JJ Letterio, CL Mackall, A Saitoh, XJ Wang, DR Roop, ...","The Journal of clinical investigation 100 (3), 575-581",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16494125939286098994,138,1997
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity,"E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, ...","Nature communications 7, 12320",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3920944425308945897,132,2016
Clinical trial designs for the early clinical development of therapeutic cancer vaccines,"RM Simon, SM Steinberg, M Hamilton, A Hildesheim, S Khleif, LW Kwak, ...","Journal of Clinical Oncology 19 (6), 1848-1854",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15081707185956594173,131,2001
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas,"CL Mackall, EH Rhee, EJ Read, HM Khuu, SF Leitman, D Bernstein, ...","Clinical Cancer Research 14 (15), 4850-4858",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3612163094967772695,129,2008
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation,"NN Shah, K Baird, CP Delbrook, TA Fleisher, ME Kohler, S Rampertaap, ...","Blood 125 (5), 784-792",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1727528316974076657,127,2015
The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer,"DW Lee, DM Barrett, C Mackall, R Orentas, SA Grupp","Clinical Cancer Research 18 (10), 2780-2790",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8673809133601408011,122,2012
Bax deficiency partially corrects interleukin-7 receptor α deficiency,"AR Khaled, WQ Li, J Huang, TJ Fry, AS Khaled, CL Mackall, K Muegge, ...","Immunity 17 (5), 561-573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16393348211178320036,117,2002
Potential Use of Imatinib in Ewing’s Sarcoma: Evidence for ,"MS Merchant, CW Woo, CL Mackall, CJ Thiele","Journal of the National Cancer Institute 94 (22), 1673-1679",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16709723388826963127,116,2002
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity,"W Lundström, S Highfill, STR Walsh, S Beq, E Morse, I Kockum, ...","Proceedings of the National Academy of Sciences 110 (19), E1761-E1770",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12903280842037178181,115,2013
IL-7 in human health and disease,"W Lundström, NM Fewkes, CL Mackall","Seminars in immunology 24 (3), 218-224",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16085901844983836167,114,2012
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults,"CL Mackall, D Stein, TA Fleisher, MR Brown, FT Hakim, CV Bare, ...","Blood 96 (2), 754-762",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18045803843221039509,105,2000
Modulating T‐cell homeostasis with IL‐7: preclinical and clinical studies,"CM Capitini, AA Chisti, CL Mackall","Journal of internal medicine 266 (2), 141-153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4555970602413876214,104,2009
The Immune System: Effector and Torget of Groff-Versus-Host Disease,"FT Hakim, CL Mackall","Graft-vs.-Host Disease, 257",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3491178135672672903,98,1996
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer,"H Zhang, I Maric, MJ DiPrima, J Khan, RJ Orentas, RN Kaplan, ...","Blood 122 (7), 1105-1113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15575673604694158454,97,2013
Focus on sarcomas,"CL Mackall, PS Meltzer, LJ Helman","Cancer cell 2 (3), 175-178",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12880329540842829582,97,2002
Phase I clinical trial of ipilimumab in pediatric patients with advanced solid tumors,"MS Merchant, M Wright, K Baird, LH Wexler, C Rodriguez-Galindo, ...","Clinical Cancer Research 22 (6), 1364-1370",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17809789719224472430,96,2016
Association of serum interleukin-7 levels with the development of acute graft-versus-host disease,"RM Dean, T Fry, C Mackall, SM Steinberg, F Hakim, D Fowler, J Odom, ...","Journal of Clinical Oncology 26 (35), 5735",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17087717473183607674,94,2008
Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo,"M Moniuszko, T Fry, WP Tsai, M Morre, B Assouline, P Cortez, MG Lewis, ...","Journal of virology 78 (18), 9740-9749",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10569071741745382215,92,2004
"Background to hematopoietic cell transplantation, including post transplant immune recovery","C Mackall, T Fry, R Gress, K Peggs, J Storek, A Toubert","Bone marrow transplantation 44 (8), 457",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15448988830190261269,91,2009
Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution,"TJ Fry, M Sinha, M Milliron, YW Chu, V Kapoor, RE Gress, E Thomas, ...","Blood 104 (9), 2794-2800",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3265720412149191961,91,2004
Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis,"HU Kontny, K Hämmerle, R Klein, P Shayan, CL Mackall, CM Niemeyer","Cell death and differentiation 8 (5), 506",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6284269403195724351,90,2001
Interferon γ Enhances the Effectiveness of Tumor Necrosis Factor-Related Apoptosis–Inducing Ligand Receptor Agonists in a Xenograft Model of Ewing’s Sarcoma,"MS Merchant, X Yang, F Melchionda, M Romero, R Klein, CJ Thiele, ...","Cancer research 64 (22), 8349-8356",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4587370205850562315,88,2004
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells,"A Üren, MS Merchant, CJ Sun, MI Vitolo, Y Sun, M Tsokos, PB Illei, ...","Oncogene 22 (15), 2334",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17669369990440955213,88,2003
Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors,"MS Merchant, JI Geller, K Baird, AJ Chou, S Galli, A Charles, M Amaoko, ...","Journal of Clinical Oncology 30 (33), 4141",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14051434755375438956,79,2012
Persistent psychological distress in long‐term survivors of pediatric sarcoma: the experience at a single institution,"L Wiener, H Battles, D Bernstein, L Long, J Derdak, CL Mackall, ...","Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13002178567743254520,79,2006
Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future,"TJ Fry, CL Mackall","Bone marrow transplantation 35 (S1), S53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5459510217079503877,79,2005
Molecular confirmation of Ewing sarcoma,"R Dagher, TA Pham, L Sorbara, S Kumar, L Long, D Bernstein, C Mackall, ...","Journal of pediatric hematology/oncology 23 (4), 221-224",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17604087080632343169,78,2001
Demodicidosis in childhood acute lymphoblastic leukemia: an opportunistic infection occurring with immunosuppression,"SP Ivy, CL Mackall, L Gore, RE Gress, AH Hartley","The Journal of pediatrics 127 (5), 751-754",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14706494835880360112,78,1995
Reduction of MDSCs with all-trans retinoic acid improves CAR therapy efficacy for sarcomas,"AH Long, SL Highfill, Y Cui, JP Smith, AJ Walker, S Ramakrishna, ...","Cancer immunology research 4 (10), 869-880",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9769604975766068412,77,2016
Simplified process for the production of anti–CD19-CAR–engineered T cells,"B Tumaini, DW Lee, T Lin, L Castiello, DF Stroncek, C Mackall, A Wayne, ...","Cytotherapy 15 (11), 1406-1415",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17524042506066555673,77,2013
Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection,"C Fluur, A De Milito, TJ Fry, N Vivar, L Eidsmo, A Atlas, C Federici, ...","The Journal of Immunology 178 (8), 5340-5350",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7637051974421996788,75,2007
A dose effect of IL-7 on thymocyte development,"N El Kassar, PJ Lucas, DB Klug, M Zamisch, M Merchant, CV Bare, ...","Blood 104 (5), 1419-1427",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17161078079004127151,74,2004
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin,"X Wan, SY Kim, LM Guenther, A Mendoza, J Briggs, C Yeung, D Currier, ...","Oncogene 28 (38), 3401",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4921719171797443798,73,2009
Immune-based therapies for childhood cancer,"CL Mackall, MS Merchant, TJ Fry","Nature reviews Clinical oncology 11 (12), 693",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14342164259860863024,72,2014
Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapy,"C Mackall, J Berzofsky, LJ Helman","Clinical Orthopaedics and Related Research® 373, 25-31",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2826704399526428696,72,2000
Current concepts of thymic aging,"TJ Fry, CL Mackall","Seminars in Immunopathology 24 (1), 7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9976865196469586746,71,2002
Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers,"RJ Orentas, JJ Yang, X Wen, JS Wei, CL Mackall, J Khan","Frontiers in oncology 2, 194",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3913855023065295361,67,2012
Treatment late effects in long‐term survivors of pediatric sarcoma,"P Mansky, A Arai, P Stratton, D Bernstein, L Long, J Reynolds, D Chen, ...","Pediatric blood & cancer 48 (2), 192-199",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8673419346286931396,65,2007
Thromboembolic events in children and young adults with pediatric sarcoma,"I Paz-Priel, L Long, LJ Helman, CL Mackall, AS Wayne","Journal of clinical oncology 25 (12), 1519-1524",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4507742429681704021,63,2007
Cytokine signals in T-cell homeostasis,"M Guimond, TJ Fry, CL Mackall","Journal of Immunotherapy 28 (4), 289-294",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8876125768439006492,63,2005
Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma,"HU Kontny, TM Lehrnbecher, SJ Chanock, CL Mackall","Cancer research 58 (24), 5842-5849",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2621054840868456917,61,1998
A genetical analysis of diversity and asymmetry in finger ridge counts,"NG Martin, JL Jinks, HS Berry, DZ Loesch","Heredity 48 (3), 393","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16813854900570895235,18119478553952953172",61,1982
Tumor antigen and receptor densities regulate efficacy of a chimeric antigen receptor targeting anaplastic lymphoma kinase,"AJ Walker, RG Majzner, L Zhang, K Wanhainen, AH Long, SM Nguyen, ...","Molecular Therapy 25 (9), 2189-2201",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13561746501791810784,60,2017
Metabolic syndrome traits in long‐term survivors of pediatric sarcoma,"KE Hoffman, J Derdak, D Bernstein, JC Reynolds, NA Avila, L Gerber, ...","Pediatric blood & cancer 50 (2), 341-346",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1436311119138522566,60,2008
Novel gamma-chain cytokines as candidate immune modulators in immune therapies for cancer,"NM Fewkes, CL Mackall","The Cancer Journal 16 (4), 392-398",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13491676362272647798,59,2010
CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or …,"M Terabe, C Khanna, S Bose, F Melchionda, A Mendoza, CL Mackall, ...","Cancer Research 66 (7), 3869-3875",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=41469995668033170,59,2006
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas,"CW Mount, RG Majzner, S Sundaresh, EP Arnold, M Kadapakkam, ...","Nature medicine 24 (5), 572",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3832257269019425486,58,2018
In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis,"M Guimond, AG Freud, HC Mao, J Yu, BW Blaser, JW Leong, ...","The Journal of Immunology 184 (6), 2769-2775",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13318698092987316803,57,2010
Functional outcomes and life satisfaction in long-term survivors of pediatric sarcomas,"LH Gerber, K Hoffman, U Chaudhry, E Augustine, R Parks, M Bernad, ...","Archives of physical medicine and rehabilitation 87 (12), 1611-1617",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1239311071156816508,57,2006
Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. 2015; 5 (12): 1282–95. doi: 10.1158/2159-8290,"E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ...",CD-15-1020.[PMC free article][PubMed][Cross Ref],https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7007822659873280372,57,0
"T-Cell Immunotherapy: Looking Forward: T Cell Immunotherapy: Optimizing Trial Design Bethesda, Maryland 10-11 September 2013","J Corrigan-Curay, HP Kiem, D Baltimore, M O'reilly, RJ Brentjens, ...","Molecular Therapy 22 (9), 1564-1574",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6430046946770585226,56,2014
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts,"Y Cui, H Zhang, J Meadors, R Poon, M Guimond, CL Mackall","Blood 114 (18), 3831-3840",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8132980764377254770,56,2009
Tumor antigen escape from CAR T-cell therapy,"RG Majzner, CL Mackall","Cancer discovery 8 (10), 1219-1226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5438662212101815137,54,2018
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels,"PJ Mansky, DJ Liewehr, SM Steinberg, GP Chrousos, NA Avila, L Long, ...","Journal of pediatric hematology/oncology 24 (6), 440-446",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7551261500358179816,54,2002
Going back to class I: MHC and immunotherapies for childhood cancer,"KB Haworth, JL Leddon, CY Chen, EM Horwitz, CL Mackall, TP Cripe","Pediatric blood & cancer 62 (4), 571-576",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5753091912906917455,50,2015
Minimal residual disease negative complete remissions following anti-CD22 chimeric antigen receptor (CAR) in children and young adults with relapsed/refractory acute …,"NN Shah, M Stetler-Stevenson, CM Yuan, H Shalabi, B Yates, C Delbrook, ...","Blood 128 (22), 650-650",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2558290885216711837,49,2016
Interferon-γ sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering …,"A Lissat, T Vraetz, M Tsokos, R Klein, M Braun, N Koutelia, P Fisch, ...","The American journal of pathology 170 (6), 1917-1930",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4331607021908181761,48,2007
Immune reconstitution: from stem cells to lymphocytes,"GM Crooks, K Weinberg, C Mackall","Biology of Blood and Marrow Transplantation 12 (1), 42-46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4608847217171753076,47,2006
Harnessing the immunotherapy revolution for the treatment of childhood cancers,"RG Majzner, S Heitzeneder, CL Mackall","Cancer Cell 31 (4), 476-485",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10960369301987335278,46,2017
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy,"ECC Wong, VE Maher, K Hines, J Lee, CS Carter, T Goletz, W Kopp, ...","Cytotherapy 3 (1), 19-29",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2317316900980071743,46,2001
Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1 c259T cells in synovial sarcoma,"SP D'Angelo, L Melchiori, MS Merchant, D Bernstein, J Glod, R Kaplan, ...","Cancer discovery 8 (8), 944-957",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4102460109441297158,45,2018
Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells,"DF Stroncek, J Ren, DW Lee, M Tran, SE Frodigh, M Sabatino, H Khuu, ...","Cytotherapy 18 (7), 893-901",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3945671905340411881,45,2016
Immunotherapy targets in pediatric cancer,"RJ Orentas, DW Lee, C Mackall","Frontiers in oncology 2, 3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3319280602647083124,45,2012
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells,"H Zhang, Y Cui, N Voong, M Sabatino, DF Stroncek, S Morisot, CI Civin, ...","Journal of immunotherapy (Hagerstown, Md.: 1997) 34 (2), 187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11062617757045602072,45,2011
Activation of hematopoietic stem/progenitor cells promotes immunosuppression within the pre–metastatic niche,"AJ Giles, CM Reid, JDW Evans, M Murgai, Y Vicioso, SL Highfill, M Kasai, ...","Cancer research 76 (6), 1335-1347",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15341839740754375645,44,2016
GVHD: a continuing barrier to the safety of allogeneic transplantation,"P Reddy, M Arora, M Guimond, CL Mackall","Biology of Blood and Marrow Transplantation 15 (1), 162-168",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1197732384289954817,44,2009
Adjuvant immunotherapy to improve outcome in high-risk pediatric sarcomas,"MS Merchant, D Bernstein, M Amoako, K Baird, TA Fleisher, M Morre, ...","Clinical Cancer Research 22 (13), 3182-3191",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15527062340366481129,43,2016
Tumor expression of 4-1BB ligand sustains tumor lytic T cells,"H Zhang, MS Merchant, KS Chua, C Khanna, LJ Helman, B Telford, ...","Cancer biology & therapy 2 (5), 579-586",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5109325178706785137,42,2003
Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma,"KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ...","Cancer cell 32 (3), 295-309. e12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2364050545533547880,41,2017
Long-term outcomes following CD19 CAR T cell therapy for B-ALL are superior in patients receiving a fludarabine/cyclophosphamide preparative regimen and post-CAR hematopoietic …,"DW Lee, M Stetler-Stevenson, CM Yuan, NN Shah, C Delbrook, B Yates, ...","Blood 128 (22), 218-218",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4051006439797550193,40,2016
Immunomagnetic purging of Ewing’s sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction,"ME Merino, F Navid, BL Christensen, JA Toretsky, LJ Helman, ...","Journal of Clinical Oncology 19 (16), 3649-3659",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14794349861714316043,40,2001
Pediatric large‐volume leukapheresis: a single institution experience with heparin versus citrate‐based anticoagulant regimens,"CD Bolan, YY Yau, HC Cullis, ME Horwitz, CL Mackall, A John Barrett, ...","Transfusion 44 (2), 229-238",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10603504526008968671,38,2004
Assessment of programmed death‐ligand 1 expression and tumor‐associated immune cells in pediatric cancer tissues,"RG Majzner, JS Simon, JF Grosso, D Martinez, BR Pawel, M Santi, ...","Cancer 123 (19), 3807-3815",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10005665973848294682,37,2017
"Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine","S Jankelevich, BU Mueller, CL Mackall, S Smith, S Zwerski, LV Wood, ...","The Journal of infectious diseases 183 (7), 1116-1120",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15224420867415036846,36,2001
"Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity","KY Kwong, S Baskar, H Zhang, CL Mackall, C Rader","Journal of molecular biology 384 (5), 1143-1156",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2457495499286665715,35,2008
Safety and response of incorporating CD19 chimeric antigen receptor T cell therapy in typical salvage regimens for children and young adults with acute lymphoblastic leukemia,"DW Lee, M Stetler-Stevenson, CM Yuan, TJ Fry, NN Shah, C Delbrook, ...","Blood 126 (23), 684-684",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4510372150008276660,34,2015
Dysregulation of IL-15-mediated T-cell homeostasis in TGF-β dominant-negative receptor transgenic mice,"PJ Lucas, SJ Kim, CL Mackall, WG Telford, YW Chu, FT Hakim, RE Gress","Blood 108 (8), 2789-2795",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15190598365454705445,34,2006
"NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the …","MS Cairo, CT Jordan, CC Maley, C Chao, A Melnick, SA Armstrong, ...","Biology of Blood and Marrow Transplantation 16 (6), 709-728",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7780243660049118645,33,2010
Bone marrow deficient in IFN-γ signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect,"CM Capitini, S Herby, M Milliron, MR Anver, CL Mackall, TJ Fry","Blood 113 (20), 5002-5009",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18059832487022425217,33,2009
Immune reconstitution prevents metastatic recurrence of murine osteosarcoma,"MS Merchant, F Melchionda, M Sinha, C Khanna, L Helman, CL Mackall","Cancer immunology, immunotherapy 56 (7), 1037-1046",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4072557556786599684,33,2007
"In vivo fluorescence imaging of the activity of CEA TCB, a novel T-cell bispecific antibody, reveals highly specific tumor targeting and fast induction of T-cell–mediated tumor …","S Lehmann, R Perera, HP Grimm, J Sam, S Colombetti, T Fauti, L Fahrni, ...","Clinical Cancer Research 22 (17), 4417-4427",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17960597965226648938,32,2016
T-cell adoptive immunotherapy for acute lymphoblastic leukemia,"TJ Fry, CL Mackall","Hematology 2013, the American Society of Hematology Education Program Book …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7168681083812729552,32,2013
Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches,"TJ Fry, JL Shand, M Milliron, SK Tasian, CL Mackall","Cancer immunology, immunotherapy 58 (8), 1257-1264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13673577791300362130,32,2009
Ewing sarcoma family of tumors in unusual sites: confirmation by rt-PCR,"AA Ahmed, VE Nava, T Pham, JK Taubenberger, JH Lichy, L Sorbara, ...","Pediatric and Developmental Pathology 9 (6), 488-495",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16214865578840140876,32,2006
IL-7 in allogeneic transplant: clinical promise and potential pitfalls,"KM Snyder, CL Mackall, TJ Fry","Leukemia & lymphoma 47 (7), 1222-1228",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11354907603818458814,32,2006
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation …,"LT Van Den Broeke, CD Pendleton, C Mackall, LJ Helman, JA Berzofsky","Cancer research 66 (3), 1818-1823",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=695940047144878620,31,2006
Escape from immune surveillance does not result in tolerance to tumor-associated antigens,"F Melchionda, MK McKirdy, F Medeiros, TJ Fry, CL Mackall","Journal of immunotherapy 27 (5), 329-338",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4781474182187776070,31,2004
Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens,"DRA Prieto, DJ Johann Jr, BR Wei, X Ye, KC Chan, DV Nissley, ...","Biomarkers in medicine 8 (2), 269-286",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15649896600474067207,30,2014
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas,"E Fox, BC Widemann, DS Hawkins, N Jayaprakash, R Dagher, AA Aikin, ...","Clinical Cancer Research 15 (23), 7361-7367",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10174314947086706652,29,2009
Interleukin-7 and immunorestoration in HIV: beyond the thymus,"TJ Fry, CL Mackall","Journal of hematotherapy & stem cell research 11 (5), 803-807",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5211893084279607490,29,2002
Thymic function in HIV infection,"R Hazra, C Mackall","Current HIV/AIDS Reports 2 (1), 24-28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3445477111239382105,27,2005
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance,"MM Boyiadzis, MV Dhodapkar, RJ Brentjens, JN Kochenderfer, ...","Journal for immunotherapy of cancer 6 (1), 1-12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14963782371846681120,26,2018
Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibody,"X Du, L Xiang, C Mackall, I Pastan","Clinical Cancer Research 17 (18), 5926-5934",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17938099754386021955,26,2011
Perspective on potential clinical applications of recombinant human interleukin-7,"C Sportès, RE Gress, CL Mackall","Annals of the New York Academy of Sciences 1182, 28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15889168280080422437,26,2009
Langerhans Cells in the TGFβ1 Null Mouse,"TA Borkowski, JJ Letterio, CL Mackall, A Saitoh, AG Farr, XJ Wang, ...","Dendritic Cells in Fundamental and Clinical Immunology, 307-310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1376795019886663483,26,1997
Autologous lymphapheresis for the production of chimeric antigen receptor T cells,"ES Allen, DF Stroncek, J Ren, AF Eder, KA West, TJ Fry, DW Lee, ...","Transfusion 57 (5), 1133-1141",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7906957203199635731,25,2017
Cytokines as adjuvants for vaccine and cellular therapies for cancer,"CM Capitini, TJ Fry, CL Mackall","American journal of immunology 5 (3), 65",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13102258934592956444,25,2009
Intramedullary Ewing sarcoma of the spinal cord: Consequences of molecular diagnostics: Case report,"RJ Weil, Z Zhuang, S Pack, S Kumar, L Helman, BG Fuller, CL Mackall, ...","Journal of Neurosurgery: Spine 95 (2), 270-275",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5880590043693048306,25,2001
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells,"DF Stroncek, DW Lee, J Ren, M Sabatino, S Highfill, H Khuu, NN Shah, ...","Journal of translational medicine 15 (1), 59",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7470640931359661005,24,2017
Programming CAR-T cells to kill cancer,"L Labanieh, RG Majzner, CL Mackall","Nature biomedical engineering 2 (6), 377-391",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9013255335450025993,23,2018
"CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors","RG Majzner, JL Theruvath, A Nellan, S Heitzeneder, Y Cui, CW Mount, ...","Clinical Cancer Research 25 (8), 2560-2574",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15990913228451966408,21,2019
Murine rhabdomyosarcoma is immunogenic and responsive to T‐cell‐based immunotherapy,"JL Meadors, Y Cui, QR Chen, YK Song, J Khan, G Merlino, M Tsokos, ...","Pediatric blood & cancer 57 (6), 921-929",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17675942728331408013,21,2011
Induction of immune response after allogeneic Wilms' tumor 1 dendritic cell vaccination and donor lymphocyte infusion in patients with hematologic malignancies and post …,"NN Shah, DM Loeb, H Khuu, D Stroncek, T Ariyo, M Raffeld, C Delbrook, ...","Biology of Blood and Marrow Transplantation 22 (12), 2149-2154",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8166234883359841869,20,2016
Current approach to pediatric soft tissue sarcomas,"MS Merchant, CL Mackall","The oncologist 14 (11), 1139-1153",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=66561788772884112,20,2009
CNS Endothelial Cell Activation Emerges as a Driver of CAR T Cell–Associated Neurotoxicity,"CL Mackall, DB Miklos","Cancer discovery 7 (12), 1371-1373",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17466965535868413339,19,2017
What limits immune reconstitution in HIV infection? Divergent tools converge on thymic function,"TJ Fry, CL Mackall","Aids 15 (14), 1881-1882",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2150093484956448747,19,2001
ADVL1412: Initial results of a phase I/II study of nivolumab and ipilimumab in pediatric patients with relapsed/refractory solid tumors—A COG study.,"KL Davis, E Fox, JM Reid, X Liu, CG Minard, B Weigel, C Mackall","Journal of Clinical Oncology 35 (15_suppl), 10526-10526",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=414263489977914328,18,2017
Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation,"NM Fewkes, AC Krauss, M Guimond, JL Meadors, S Dobre, CL Mackall","Blood 115 (20), 4120-4129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6206014973013182902,18,2010
Immune-based therapeutics for pediatric cancer,"CM Capitini, CL Mackall, AS Wayne","Expert opinion on biological therapy 10 (2), 163-178",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11871452411632070322,18,2010
"O2 reserve of left ventricle of isolated, saline-perfused rabbit heart","NF Paradise, JM Surmitis, CL Mackall",American Journal of Physiology-Heart and Circulatory Physiology 247 (5 …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16548481954114027196,18,1984
CAR T cell therapy: inroads to response and resistance,"CE Brown, CL Mackall","Nature Reviews Immunology 19 (2), 73",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6813071894305615771,17,2019
Phase 1 study of CD19/CD22 bispecific chimeric antigen receptor (CAR) therapy in children and young adults with B cell acute lymphoblastic leukemia (ALL),"LM Schultz, KL Davis, C Baggott, C Chaudry, AC Marcy, S Mavroukakis, ...","Blood 132 (Suppl 1), 898-898",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8022953442077304622,17,2018
Anti-CD19 chimeric antigen receptor (CAR) T cells produce complete responses with acceptable toxicity but without chronic B-cell aplasia in children with relapsed or refractory …,"NN Shah, M Stetler-Stevenson, M Sabatino, C Delbrook, K Richards, ...","Blood 122 (21), 68-68",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16433110002667672182,17,2013
Molecular alterations in pediatric sarcomas: potential targets for immunotherapy,"TJ Goletz, CL Mackall, JA Berzofsky, LJ Helman","Sarcoma 2 (2), 77-87",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15838084962467873079,17,1998
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop,"P Hingorani, K Janeway, BD Crompton, C Kadoch, CL Mackall, J Khan, ...","Cancer genetics 209 (5), 182-194",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6088441557707171880,16,2016
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas,"K Baird, TJ Fry, SM Steinberg, MR Bishop, DH Fowler, CP Delbrook, ...","Biology of Blood and Marrow Transplantation 18 (5), 698-707",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5846103926635155826,16,2012
Immunotherapy of childhood cancer: from biologic understanding to clinical application,"AS Wayne, CM Capitini, CL Mackall","Current opinion in pediatrics 22 (1), 2",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10524313317127625136,15,2010
Clinical activity and persistence of anti-CD22 chimeric antigen receptor in children and young adults with relapsed/refractory acute lymphoblastic leukemia (ALL),"TJ Fry, M Stetler-Stevenson, NN Shah, CM Yuan, B Yates, C Delbrook, ...","Blood 126 (23), 1324-1324",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4366483891101179092,14,2015
Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience,"PC Nathan, M Tsokos, L Long, D Bernstein, LH Wexler, CL Mackall, ...","Pediatric blood & cancer 44 (5), 449-454",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16816950581403082097,14,2005
"Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1","C Mackall, WD Tap, J Glod, M Druta, WA Chow, DM Araujo, SA Grupp, ...","Journal of Clinical Oncology 35 (15_suppl), 3000-3000",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4427982659336694955,13,2017
Phase I experience with a bi-specific CAR targeting CD19 and CD22 in adults with B-cell malignancies,"N Hossain, B Sahaf, M Abramian, JY Spiegel, K Kong, S Kim, ...","Blood 132 (Suppl 1), 490-490",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11173554895009447271,12,2018
Systematic evaluation of neurotoxicity in children and young adults undergoing CD22 chimeric antigen receptor T-cell therapy,"H Shalabi, PL Wolters, S Martin, MA Toledo-Tamula, MC Roderick, ...","Journal of Immunotherapy 41 (7), 350-358",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14568843538088586715,12,2018
Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation,"CM Capitini, J Derdak, MS Hughes, CP Love, K Baird, CL Mackall, TJ Fry","Journal of pediatric hematology/oncology 31 (2), 142",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6094615129285638312,12,2009
Fludarabine and neurotoxicity in engineered T-cell therapy,"KL Lowe, CL Mackall, E Norry, R Amado, BK Jakobsen, G Binder","Gene therapy 25 (3), 176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=698084771571239425,11,2018
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy,"BB Duncan, SL Highfill, H Qin, N Bouchkouj, S Larabee, P Zhao, ...","Journal of immunotherapy (Hagerstown, Md.: 1997) 36 (8)",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4617693122255585209,11,2013
High-dose chemotherapy for rhabdomyosarcoma: where do we go from here,"CL Mackall, LJ Helman","Journal of pediatric hematology/oncology 23 (5), 266-267",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8728856070270469894,11,2001
CD22-CAR T cells induce remissions in CD19-CAR naïve and resistant B-ALL,"TJ Fry, NN Shah, RJ Orentas, M Stetler-Stevenson, CM Yuan, ...","Nature medicine 24 (1), 20",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3892756567067495918,10,2018
Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison,"RJ Orentas, J Nordlund, J He, S Sindiri, C Mackall, TJ Fry, J Khan","Frontiers in oncology 4, 134",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14175178955367911939,10,2014
Enhancing immune reconstitution: from bench to bedside,"M van Den Brink, AM Leen, K Baird, M Merchant, C Mackall, CM Bollard","Biology of Blood and Marrow Transplantation 19 (1), S79-S83",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3335731246348067368,10,2013
EXLOITING GENETIC ALTERATIONS TO DESIGN NOVEL THERAPIES FOR CANCER,"TP Cripe, CL Mackall","Hematology/Oncology Clinics 15 (4), 657-675",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5732459898175918728,10,2001
Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrow,"GN Schwartz, F Hakim, J Zujewski, JM Szabo, R Cepada, D Riseberg, ...","British journal of haematology 92 (3), 537-547",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1388965523405473558,10,1996
Genetically engineered NY-ESO-1 specific T cells in HLA-A201+ patients with advanced cancers.,"MS Merchant, MC Cristea, EA Stadtmauer, WD Tap, SP D'Angelo, ...","Journal of Clinical Oncology 33 (15_suppl), TPS3102-TPS3102",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15082546006865111486,9,2015
"Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy regimen","R Hazra, S Jankelevich, CL Mackall, NA Avila, P Wolters, L Civitello, ...","Viral immunology 20 (1), 131-141",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9949495125811172895,9,2007
Combined immune reconstitution/tumor vaccination to induce anti-tumor immune responses in the setting of minimal residual neoplastic disease.,"CL Mackall, LM Long, R Dagher, D Bernstein, TA Fleisher, MR Brown, ...","Blood 94 (10), 133A-133A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1978118775824336887,9,1999
Ipilimumab: First results of a phase I trial in pediatric patients with advanced solid tumors.,"MS Merchant, K Baird, LH Wexler, C Rodriguez-Galindo, C Mackall","Journal of Clinical Oncology 30 (15_suppl), 9545-9545",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=736895687477729140,8,2012
Enhancing immune reconstitution after stem cell transplants with cytokines,CL Mackall,"Cytotherapy 4 (5), 427-428",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=893693939938846338,8,2002
Clinical lessons learned from the first leg of the CAR T cell journey,"RG Majzner, CL Mackall","Nature medicine 25 (9), 1341-1355",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2666381339611330322,7,2019
Neurotoxicity Associated with a High-Affinity GD2 CAR,"RG Majzner, EW Weber, RC Lynn, P Xu, CL Mackall","Cancer immunology research 6 (4), 494-495",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11068347646592509969,7,2018
Impact of two measures of micrometastatic disease on clinical outcomes in patients with newly diagnosed ewing sarcoma: a report from the children's oncology group,"KT Vo, JV Edwards, CL Epling, E Sinclair, DS Hawkins, HE Grier, ...","Clinical Cancer Research 22 (14), 3643-3650",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10769067318109141496,7,2016
Assessment of PD-L1 expression and tumor-associated lymphocytes in pediatric cancer tissues,"RG Majzner, JS Simon, JF Grosso, D Martinez, B Pawel, M Santi-Vincini, ...","Cancer Research 75 (15 Supplement), 249-249",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12573930962323262566,7,2015
Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL,"Y Cui, M Onozawa, HR Garber, L Samsel, Z Wang, JP McCoy, S Burkett, ...","Blood 125 (19), 2958-2967",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16521365923509084971,7,2015
In search of targeted therapies for childhood cancer,C Mackall,"Frontiers in oncology 1, 18",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=908786132332068375,7,2011
T-cell-based therapies for malignancy and infection in childhood,"N Ahmed, HE Heslop, CL Mackall","Pediatric Clinics 57 (1), 83-96",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3061952961090497231,7,2010
Clinical implications of immune reconstitution following hematopoietic stem cell transplantation,"KS Peggs, AC Krauss, CL Mackall","Hematopoietic Stem Cell Transplantation, 131-154",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11117042728743600140,7,2009
Therapy for metastatic ESFT: is it time to ask new questions?,"KM Snyder, CL Mackall","Pediatric blood & cancer 49 (2), 115-116",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14476328819196623199,7,2007
Pharmacologic control of CAR-T cell function using dasatinib,"EW Weber, RC Lynn, E Sotillo, J Lattin, P Xu, CL Mackall","Blood advances 3 (5), 711",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4336285118238751075,6,2019
Immunotherapy for acute lymphoblastic leukemia: from famine to feast,"KL Davis, CL Mackall","Blood advances 1 (3), 265-269",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10289485344772834353,6,2016
Tocilizumab-refractory cytokine release syndrome (CRS) triggered by chimeric antigen receptor (CAR)-transduced T cells may have distinct cytokine profiles compared to typical CRS,"K Ishii, H Shalabi, B Yates, C Delbrook, CL Mackall, TJ Fry, NN Shah","Blood 128 (22), 3358-3358",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=134144508410836028,6,2016
Highlights of the first international “immunotherapy in pediatric oncology: progress and challenges” meeting,"CM Capitini, LJN Cooper, RM Egeler, R Handgretinger, F Locatelli, ...","Journal of pediatric hematology/oncology 31 (4), 227",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=185711266986177869,6,2009
Thymic stromal lymphopoietin is not necessary or sufficient to mediate the thymopoietic effects of keratinocyte growth factor,"M Guimond, WJ Leonard, R Spolski, SW Rossi, RG Veenstra, ...","Blood 111 (2), 969-970",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10692197204582907240,6,2008
The immune system in graft-vs.-host disease: target and effector organ,"CL Mackall, FT Hakim, A Velardi","Graft vs. Host Disease, 223-258",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15438870173576475738,6,2004
Principles and practice of pediatric oncology,"MA Smith, LAG Ries, JG Gurney, ML Bondy, SE Plon, D Malkin, AT Look, ...","Edited by: Pizzo PAPoplack GD 4, 1-12",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14613020110850486346,6,2002
Engineering a designer immunotherapy,CL Mackall,"Science 359 (6379), 990-991",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7951568543173061207,5,2018
Intent-to-treat results of a Phase I trial of CD19 chimeric antigen receptor engineered T cells using a consistent treatment regimen reveals a 67% complete response rate in …,"DW Lee, M Stetler-Stevenson, M Sabatino, C Yuan, TJ Fry, NN Shah, ...","Blood 124 (21), 381-381",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1692995458518831438,5,2014
Highlights of the third international conference on immunotherapy in pediatric oncology,"C Brehm, S Huenecke, V Pfirrmann, C Rossig, CL Mackall, CM Bollard, ...","Pediatric hematology and oncology 30 (5), 349-366",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=306432621800542329,5,2013
Lexatumumab: Results of a phase I trial in pediatric patients with advanced solid tumors.,"MS Merchant, AJ Chou, A Price, JI Geller, M Tsokos, C Graham, ...","Journal of Clinical Oncology 28 (15_suppl), 9500-9500",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14196811734422964886,5,2010
Adolescents and young adults successfully restore lymphocyte homeostasis after intensive T‐cell depleting therapy for cancer,"JC Shand, PJ Mansky, MV Brown, TA Fleisher, CL Mackall","British journal of haematology 135 (2), 270-271",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7612839926493598478,5,2006
Randomized trial and pharmacokinetic study of pegfilgrastim vs. filgrastim in children and young adults with newly diagnosed sarcoma treated with dose intensive chemotherapy,"E Fox, N Jayaprakash, BC Widemann, D Hawkins, R Dagher, P Mansky, ...","Journal of Clinical Oncology 24 (18_suppl), 9020-9020",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17820068145065884792,5,2006
Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics,"SR Panch, SK Srivastava, N Elavia, A McManus, S Liu, P Jin, SL Highfill, ...","Molecular Therapy 27 (7), 1275-1285",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=305337217310621804,4,2019
Target Antigen downregulation and other mechanisms of failure after axicabtagene ciloleucel (CAR19) therapy,"J Oak, JY Spiegel, B Sahaf, Y Natkunam, SR Long, N Hossain, ...","Blood 132 (Suppl 1), 4656-4656",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8967603577440159489,4,2018
Low CD19 Antigen Density Diminishes Efficacy of CD19 CAR T Cells and Can be Overcome By Rational Redesign of CAR Signaling Domains,"RG Majzner, SP Rietberg, L Labanieh, E Sotillo, EW Weber, RC Lynn, ...","Blood 132 (Suppl 1), 963-963",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5225814612109673633,4,2018
Screening clinical cell products for replication competent retrovirus: the National Gene Vector Biorepository experience,"K Cornetta, L Duffy, SA Feldman, CL Mackall, ML Davila, KJ Curran, ...","Molecular Therapy-Methods & Clinical Development 10, 371-378",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9924815760003289816,4,2018
New developments in immunotherapy for pediatric solid tumors,"LM Schultz, R Majzner, KL Davis, C Mackall","Current opinion in pediatrics 30 (1), 30-39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2591959327317999773,4,2018
Highlights of the second international conference on “immunotherapy in pediatric oncology”,"CM Capitini, S Gottschalk, M Brenner, LJN Cooper, R Handgretinger, ...","Pediatric hematology and oncology 28 (6), 459-460",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13625933812512536336,4,2011
Hematopoietic stem cell transplantation,"MH Beers, R Berkow","The Merck Manual of diagnosis and therapy, 17th ed. Retrieved on January 24","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12078065861320861152,9529561525356583188",4,2007
The lympho-hematopoietic system: effector and target of graft-versus-host disease,CL Mackall,Graft-vs.-Host Disease,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13715562970743877296,4,2004
Targeting pediatric malignancies for T cell-mediated immune responses,"CL Mackall, LJ Helman","Current oncology reports 2 (6), 539-546",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15850860172890170328,4,2000
Mutant oncogene and tumor suppressor gene products and fusion proteins created by chromosomal translocations as targets for cancer vaccines,"VE Maher, BS Worley, D Contois, MC Smith, MJ Kelley, M Stipanov, ...","Peptide based cancer vaccines. Austin, TX. Georgetown (TX): Landes …",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10319008272460343708,4,2000
Driving CAR T cell translation forward,"L Schultz, C Mackall","Science translational medicine 11 (481), eaaw2127",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=261642754113124725,3,2019
M971 chimeric antigen receptors,"RJ Orentas, IH Pastan, DS Dimitrov, CL Mackall","US Patent App. 10/072,078",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15983726630850196241,3,2018
A prospective evaluation of neurocognitive function and neurologic symptoms in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL …,"H Shalabi, PL Wolters, S Martin, C Delbrook, B Yates, DW Lee, ...","Blood 128 (22), 1625-1625",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12826709143794846219,3,2016
Chimeric antigen receptor T-cell therapy against anaplastic lymphoma kinase (ALK) is limited by target antigen density and CAR surface expression,"RG Majzner, AJ Walker, M Murgai, L Zhang, AH Long, KM Wanhainen, ...","Cancer Research 76 (14 Supplement), 2648-2648",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9494924350000096190,3,2016
Cytokine release syndrome (CRS) in patients treated with NY-ESO-1,"C Mackall, SP D'Angelo, MC Cristea, K Odunsi, E Norry, L Pandite, ...","Journal of Clinical Oncology 34 (15_suppl), 3040-3040",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1479359943602260931,3,2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent le ukaemic plasticity.,"E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, ...",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16664265287088949774,3,2016
Optimizing engineered TCR T cell therapy for synovial sarcoma,"S D'Angelo, M Merchant, L Melchiori, H Zhang, L Pandite, T Holdich, ...","Journal for immunotherapy of cancer 3 (2), P159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9363455181537070022,3,2015
Alternative splicing of CD19 mRNA in leukemias escaping CART-19 immunotherapy eliminates the cognate epitope and contributes to treatment failure,"E Sotillo, D Barrett, A Bagashev, K Black, C Lanauze, D Oldridge, ...","Cancer Research 75 (15 Supplement), 3143-3143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18196924448495112320,3,2015
Emerging immunotherapies for cancer and their potential for application in pediatric oncology,"RJ Orentas, CL Mackall",Critical Reviews™ in Oncogenesis 20 (3-4),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6386709972472505167,3,2015
Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors,"SL Highfill, AH Long, RJ Orentas, CL Mackall","Journal for immunotherapy of cancer 1 (1), P265",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11304376142190423541,3,2013
Abstract LB-138: Autologous-collected anti-cd19 chimeric antigen receptor (CAR) T cells for acute lymphocytic leukemia (ALL) and Non-Hodgkin's lymphoma (NHL) in children who …,"DW Lee, N Shah, M Stetler-Stevenson, M Sabatino, K Richards, ...","Cancer Research 73 (8 Supplement), LB-138-LB-138",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3916679046760070684,3,2013
Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma,"CD Fitzhugh, B Wise, K Baird, M Tsokos, L Helman, C Mackall, ...","Pediatric blood & cancer 53 (3), 496-498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14265601950492890161,3,2009
Tyrosine kinase inhibition with sunitinib facilitates thymic engraftment by modulating thymic niche accessibility,"AC Krauss, M Guimond, S Dobre, CL Mackall","Blood 112 (11), 72-72",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17101420764850503663,3,2008
Dose effect of IL-7 on thymic development.,"N El Kassar, P Lucas, S Sharrow, D Klug, CV Bare, M Merchant, ...","Blood 100 (11), 724A-724A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16826805939634841507,3,2002
Flt3 ligand: A potential new immunorestorative agent.,"TJ Fry, M Sinha, EK Thomas, CL Mackall","Blood 98 (11), 735A-735A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6985287124850175208,3,2001
Spreading the wealth: Antigen discovery in adult tumors can help hone the search for pediatric tumor antigens,CL Mackall,"Journal of Immunotherapy 24 (4), 281-282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17744486431932407380,3,2001
A potential role for IL-7 in T cell homeostasis in HIV infected patients.,"TJ Fry, LV Wood, DJ Liewehr, SM Steinberg, CL Mackall","BLOOD 94 (10), 432A-432A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10332445827901331526,3,1999
Regeneration of T cells after chemotherapy.,"G Cunnane, C O'Farrelly","The New England journal of medicine 332 (24), 1650",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7804469133322299527,3,1995
Monitoring ctDNA in r/r DLBCL patients following the CAR T-cell therapy axicabtagene ciloleucel: Day 28 landmark analysis.,"MJ Frank, NM Hossain, AA Bukhari, E Dean, JY Spiegel, GK Claire, ...","Journal of Clinical Oncology 37 (15_suppl), 7552-7552",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10730232360779849857,2,2019
Elevated Axicabtagene ciloleucel (CAR-19) expansion by immunophenotyping is associated with toxicity in diffuse large B-cell lymphoma,"JY Spiegel, B Sahaf, N Hossain, MJ Frank, G Claire, M Abramian, ...","Blood 132 (Suppl 1), 576-576",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8875092018885276232,2,2018
Enhancing the efficacy of CAR T cells,CL Mackall,"Blood 130 (Suppl 1), SCI-15-SCI-15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5387366090189130265,2,2017
"Anti-CD276 polypeptides, proteins, and chimeric antigen receptors","RJ Orentas, Z Zhu, CL Mackall, DS Dimitrov, BS Croix, S Saha","US Patent 9,790,282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1302617566882499797,2,2017
Immu-07. Checkpoint Molecule B7-h3 Is Highly Expressed On Medulloblastoma And Proves To Be A Promising Candidate For Car T Cell Immunotherapy,"J Theruvath, S Heitzeneder, R Majzner, CM Graef, K Cui, A Nellan, ...","Neuro-oncology 19 (Suppl 4), iv28","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8338573487990700816,8115123710106687775",2,2017
"A phase 1, open-label, dose escalation study of enoblituzumab (MGA271) in pediatric patients with B7-H3-expressing relapsed or refractory solid tumors.","K Desantes, JM Maris, K McDowell, C Mackall, S Shankar, J Vasselli, ...","Journal of Clinical Oncology 35 (15_suppl), TPS2596-TPS2596",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15506280916561489100,2,2017
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one,"A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...","Journal for immunotherapy of cancer 4 (1), 82",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6312032041217421627,2,2016
Open label non-randomized multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1c259 SPEAR T-cellsTM in HLA-A* 02+ patients with synovial sarcoma …,"C Mackall, S D'Angelo, S Grupp, J Glod, M Druta, W Chow, K Chagin, ...",Annals of Oncology 27 (suppl_6),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4699324914591083291,2,2016
Pregnancy associated plasma protein A (PAPP-A) is a potential novel therapeutic target in Ewing sarcoma,"S Heitzeneder, JF Shern, J Khan, CL Mackall","Cancer Research 76 (14 Supplement), 571-571",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15061281231412954678,2,2016
Autologous genetically engineered NY-ESO-1,"C Mackall, SP D'Angelo, SA Grupp, K Odunsi, MC Cristea, GP Linette, ...","Journal of Clinical Oncology 34 (15_suppl), TPS3101-TPS3101",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3225967249330013416,2,2016
M971 chimeric antigen receptors,"RJ Orentas, IH Pastan, DS Dimitrov, CL Mackall","US Patent App. 14/437,889",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15949985082321616577,2,2015
Neutralization of murine myeloid suppressor cells enhances the efficacy of GD2-specific CAR T cells directed against human sarcoma in a xenograft model (VAC11P. 1010),"S Highfill, J Smith, A Long, Y Cui, R Orentas, C Mackall","The Journal of Immunology 192 (1 Supplement), 205.11-205.11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6263370278740639020,2,2014
Autologous-Collected Donor-Derived CD19-Directed Chimeric Antigen Receptor (CD19-CAR) T Cells Induce a Complete Remission in Chemotherapy-Refractory Childhood Acute Lymphocytic …,"DW Lee, M Stetler-Stevenson, M Sabatino, B Tumaini, K Richards, ...","Blood 120 (21), 2609-2609",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12527744141759820276,2,2012
Early Clinical Experience of aAPC Activated NK-DLI Following Allogeneic PBSCT in Pediatric Solid Tumor Patients.,"K Baird, TJ Fry, M Merchant, K Richards, C Delbrook, AS Wayne, ...","Blood 120 (21), 3013-3013",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12403882975095053809,2,2012
Hematopoietic Stem Cell Transplantation,A Lopez,Embryo Project Encyclopedia,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1683257149696985759,2,2012
Soluble IL7 receptor alpha chain serves as a depot to prevent IL7 consumption (57.1),"W Lundstrom, S Walsh, C Mackall","The Journal of Immunology 186 (1 Supplement), 57.1-57.1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17600003255859900650,2,2011
Immunogenic peptides and methods of use for treating and preventing cancer,"JA Berzofsky, LT Van Den Broeke, C MacKall, LJ Helman","US Patent 7,867,977",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16662016259605068377,2,2011
Pediatric Radiation Oncology,"KK Matthay, D Haas-Kogan, LS Constine, EC Halperin, NJ Tarbell, ...",Lippincott Williams & Wilkins,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14583281727804886807,2,2005
Non-myeloablative allogeneic hematopoietic stem cell transplantation with pre-transplant immune depletion results in rapid full donor engraftment in pediatric patients with …,"TJ Fry, A Wayne, D Fowler, F Hakim, C Love, R Gress, M Bishop, ...","Biology of Blood and Marrow Transplantation 10, 36-37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13612485208624186019,2,2004
Harnessing the immune modulatory effects of IL7 for immunotherapy,"F Melchionda, TJ Fry, CL Mackall","Clinical and Applied Immunology Reviews 4 (2), 71-89",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15338922331466790758,2,2003
Abstract LB-146: Phase I CD22 CAR T-cell trial updates,"NN Shah, H Shalabi, B Yates, C Yuan, H Qin, A Ombrello, HW Wang, ...","Cancer Research 79 (13 Supplement), LB-146-LB-146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=854336530644656515,1,2019
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument,"SR Panch, OL Reddy, K Li, T Bikkani, A Rao, S Yarlagadda, S Highfill, ...",Clinical Hematology International,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10663764635993579765,1,2019
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion,"S Heitzeneder, E Sotillo, JF Shern, S Sindiri, P Xu, R Jones, M Pollak, ...",JNCI: Journal of the National Cancer Institute,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7173183710100137407,1,2019
Abstract LB-112: Engineering AP1 to combat CAR T cell exhaustion,"RC Lynn, EW Weber, D Gennert, E Sotillo, R Jones, P Xu, A Satpathy, ...","Cancer Research 78 (13 Supplement), LB-112-LB-112",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7355281275176632084,1,2018
"CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors","R Majzner, A Nellan, S Heitzeneder, J Theruvath, C Mackall",PEDIATRIC BLOOD & CANCER 65,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5884944120028281668,1,2018
B7-H3 CAR T Cells Mediate In Vitro and In Vivo Activity Against Neuroblastoma Xenografts,"M Kadapakkam, R Majzner, P Xu, C Mackall",PEDIATRIC BLOOD & CANCER 65,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14068135148977164383,1,2018
Immunotherapy with Genetically Modified T Cells,"L Schultz, C Mackall","Immunotherapy in Translational Cancer Research, 101-114",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=424125798942449631,1,2018
PDTM-39. GD2-directed chimeric antigen receptor T cells as a potent immunotherapy regimen in xenograft models of diffuse intrinsic pontine glioma,"C Mount, R Majzner, S Sundaresh, E Arnold, M Kadapakkam, ...","Neuro-Oncology 19 (Suppl 6), vi198",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14508014598372249398,1,2017
"Alk antibodies, conjugates, and chimeric antigen receptors, and their use","R Orentas, C MacKall","US Patent App. 15/034,171",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15738201141524930764,1,2016
Attenuated oncolytic virus HSV1716 increases in vivo expansion of GD2-targeting CAR T cells in murine solid tumor models,"ST Haile, J Conner, C Mackall","Cancer Research 76 (14 Supplement), 2304-2304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=932667379105094454,1,2016
Assessment of PD-L1 expression and tumor associated immune cells in pediatric cancer tissues.,"RG Majzner, D Martinez, B Pawel, M Santi, P Sorensen, C Mackall, ...","Journal of Clinical Oncology 34 (15_suppl), 11542-11542",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2401389277797332220,1,2016
Myeloid Cells in Peripheral Blood Mononuclear Cell (PMBC) Concentrates Inhibit the Expansion of Chimeric Antigen Receptor (CAR) T Cells,"DF Stroncek, DW Lee, J Ren, M Sabatino, H Khuu, MS Merchant, ...","Blood 126 (23), 383-383",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16900207635240634110,1,2015
Chimeric Antigen Receptors for Cancer: Progress and Challenges,"AH Long, DW Lee, CL Mackall","Current stem cell reports 1 (4), 187-196",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6253192806837741906,1,2015
Genetically engineered NY-ESO-1-specific T cells in HLA-A2+ patients with synovial sarcoma,"MS Merchant, SP D'Angelo, H Zhang, D Bernstein, G Binder-Scholl, ...","Cancer Research 75 (15 Supplement), 4707-4707",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=944354733875601072,1,2015
4-1BB costimulation ameliorates exhaustion and prolongs in vivo persistence of chimeric antigen receptor (CAR) expressing T cells,"AH Long, WM Haso, JP Smith, AJ Walker, TJ Fry, RJ Orentas, CL Mackall","Cancer Research 75 (15 Supplement), 4702-4702",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9997699148810301895,1,2015
Recombinant human IL7 enhances naïve and T stem cell memory reconstitution and enhances repertoire diversity following cytotoxic chemotherapy (LYM5P. 705),"H Zhang, H Robins, C Mackall","The Journal of Immunology 194 (1 Supplement), 134.10-134.10",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15497609299951787981,1,2015
Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors,"N Tschernia, R Orentas, C Mackall","Journal for immunotherapy of cancer 2 (3), P39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13309224606598847928,1,2014
Synthetic chimeric antigen receptors (CARs) rapidly induce exhaustion and augmented glycolytic metabolism in human T cells and implicate persistent CD28 signaling as a driver …,"RJ Orentas, CL Mackall","Blood 122 (21), 192-192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10911169288934773577,1,2013
Autologous-collected anti-CD19 chimeric antigen receptor T cells (19CARTs) for pediatric acute lymphocytic leukemia (ALL) and non-Hodgkin lymphoma (NHL): Clinical activity and …,"DW Lee, N Shah, M Stetler-Stevenson, M Sabatino, K Richards, ...","Journal of Clinical Oncology 31 (15_suppl), 10008-10008",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7023081604196881403,1,2013
"Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines±CYT107 …","C Mackall, K Baird, DB Bernstein, BJ Wood, SM Steinberg, S Beq, ...","Journal of Clinical Oncology 31 (15_suppl), 10013-10013",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7221012994691318178,1,2013
Identifying an IDO-expressing “fibrocyte” subset of myeloid suppressor cells in pediatric cancer patients.(127.28),"H Zhang, C Mackall","The Journal of Immunology 188 (1 Supplement), 127.28-127.28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16168672532008401898,1,2012
A pilot trial of WT1 peptide-loaded allogeneic dendritic cell vaccine and donor lymphocyte infusion for WT1-expressing hematologic malignancies and post-transplant relapse,"NN Shah, D Loeb, H Khuu, D Stroncek, M Raffeld, C Delbrook, ...","Blood 118 (21), 3055-3055",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5339629693046311874,1,2011
IL-7 signaling in dendritic cells regulates CD4+ T cell homeostatic proliferation and CD4+ T cell niche size,"M Guimond, RG Veenstra, DJ Grindler, H Zhang, Y Cui, RD Murphy, ...","Nature immunology 10 (2), 149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14940774776232869909,1,2009
Dipeptidyl peptidase inhibition accelerates dendritic cell cross priming of tumor-reactive T cells resulting in regression of established tumors,"M Walsh, AC Krauss, JPE Davis, SY Kim, M Guimond, CL Mackall, TJ Fry","Blood 112 (11), 2579-2579",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15078563305109821235,1,2008
GVHD Abrogates T Cell Responses to Dendritic Cell Vaccines but Not Vaccine-Induced Proliferation.,"CM Capitini, M Guimond, CL Mackall, TJ Fry","Blood 110 (11), 1802-1802",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14660801919656984038,1,2007
IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).,"C Sportes, M Krumlauf, R Babb, L Foruraghi, J Daub, D Avila, C Chow, ...","Blood 108 (11), 871-871",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8125492279460152812,1,2006
A fine romance: IL-7 and HGFβ,CL Mackall,"Blood 107 (5), 1739-1740",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5596188328977422903,1,2006
Promising γ-Chain Cytokines for Cancer Immunotherapy,"TJ Fry, CL Mackall","Immunotherapy of Cancer, 397-414",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4400896592823022978,1,2006
Cancer therapy-induced immune modulation.,"JC Karl, CL Mackall","Cancer chemotherapy and biological response modifiers 22, 325-341",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17982374457657611658,1,2005
Toward new approaches: targeting tumor specific molecular alterations with immune-based therapy,"CL Mackall, TJ Goletz, JA Berzofsky, LJ Helman, C Cooper",Chromosomal Translocations in Human Sarcomas. Medical Intelligence Unit …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8151787062354218210,1,2002
Increased susceptibility to tolerance induction in T cell depleted hosts during immune reconstitution,"TJ Fry, BL Christensen, CL Mackall","Blood 94 (10), 320A-320A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10609347950283781799,1,1999
The skin of TGFβ1 null mice is devoid of epidermal langerhans cells (LC).,"TA Borkowski, J Letterio, C Mackall, A Farr, D Geiser, R Gress, MC Udey","Journal of Investigative Dermatology 4 (104), 568",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10735574327969658019,1,1995
Understanding Resistance to Cellular Immunotherapy,CL Mackall,2020 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR,,0,2020
c-Jun overexpression in CAR T cells induces exhaustion resistance,"RC Lynn, EW Weber, E Sotillo, D Gennert, P Xu, Z Good, H Anbunathan, ...","Nature, 1-8",,0,2019
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma,"I Ramachandran, DE Lowther, R Dryer-Minnerly, R Wang, S Fayngerts, ...","Journal for immunotherapy of cancer 7 (1), 1-14",,0,2019
Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) Transduction,"LM Schultz, S Patel, S Ramakrishna, A Bertaina, N Bhatia, J Oak, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
Infectious Complications Associated with CAR T-Cell Therapy,"L Mikkilineni, S Shahani, B Yates, SM Steinberg, T Palmore, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
Identification of Two CAR T-Cell Populations Associated with Complete Response or Progressive Disease in Adult Lymphoma Patients Treated with Axi-Cel,"Z Good, JY Spiegel, B Sahaf, MB Malipatlolla, MJ Frank, J Baird, LS Muffly, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL),"LM Schultz, LS Muffly, JY Spiegel, S Ramakrishna, N Hossain, C Baggott, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
"Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma","MJ Frank, N Hossain, A Bukhari, E Dean, JY Spiegel, GK Claire, IM Kirsch, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
"Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy","B Sworder, DM Kurtz, C Macaulay, MJ Frank, S Alig, A Garofalo, B Sahaf, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming,"F Simonetta, T Hirai, JK Lohmeyer, K Maas-Bauer, M Alvarez, ...","Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …",,0,2019
Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with acute lymphoblastic leukemia,"A Kulshrestha, H Shalabi, V Sachdev, D Rosing, S Sidenko, C Mackall, ...",JOURNAL FOR IMMUNOTHERAPY OF CANCER 7,,0,2019
Autologous T cells with NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-A* 02+ previously-treated and-untreated advanced metastatic/unresectable synovial sarcoma: A …,"S D'Angelo, JY Blay, W Chow, G Demetri, F Thistlethwaite, M Wagner, ...",JOURNAL FOR IMMUNOTHERAPY OF CANCER 7,,0,2019
Abstract PL01-05: Next-generation CAR T cells designed to overcome tumor resistance,CL Mackall,"Cancer Research 79 (13 Supplement), PL01-05-PL01-05",,0,2019
COMPOSITIONS AND METHODS FOR INHIBITING T CELL EXHAUSTION,"C Mackall, R Lynn, E Weber, E Sotillo","US Patent App. 16/221,155",,0,2019
LOCALLY ADMINISTERED CAR T CELLS DEMONSTRATE MOST FAVORABLE ROUTE OF ADMINISTRATION IN A MODEL OF ATRT: IMMU-09.,"J Theruvath, C Graef, S Heitzeneder, R Majzner, L Labanieh, C Mackall",Neuro-oncology 21,,0,2019
M971 chimeric antigen receptors,"RJ Orentas, IH Pastan, DS Dimitrov, CL Mackall","US Patent App. 16/107,271",,0,2019
Disease Detection Methodologies in Acute Lymphoblastic Leukemia (ALL): Opportunities for Improvement,"H Shalabi, C Yuan, A Kulshreshtha, A Dulau-Florea, D Salem, G Gupta, ...","Biology of Blood and Marrow Transplantation 25 (3), S108-S109",,0,2019
Abstract A007: Comparison of pretreatment conditioning on efficacy in two cohorts of a pilot study of genetically engineered NY-ESO-1c259T-cells in patients with synovial sarcoma,"SP D'Angelo, D Araujo, B Van Tine, G Demetri, M Dutra, J Glod, W Chow, ...","Cancer Immunology Research 7 (2 Supplement), A007-A007",,0,2019
Abstract A002: Autologous Tcells transduced with the affinity enhanced NY-ESO-1c259TCR in patients with synovial sarcoma expressing low levels of the NY-ESO-1 antigen,"D Araujo, S D'Angelo, G Demetri, M Druta, J Glod, W Chow, W Tap, ...","Cancer Immunology Research 7 (2 Supplement), A002-A002",,0,2019
c-Jun Overexpressing CAR-T Cells are Exhaustion-Resistant and Mediate Enhanced Antitumor Activity,"RC Lynn, EW Weber, D Gennert, E Sotillo, P Xu, Z Good, H Anbunathan, ...","bioRxiv, 653725",,0,2019
Anti-cd276 chimeric antigen receptors,"CL Mackall, YK Cui","US Patent App. 15/757,728",,0,2018
1 Study of CD19/CD22 Bispecific Chimeric Antigen Receptor (CAR) Therapy in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia (ALL),"LM Schultz, KL Davis, C Baggott, C Chaudry, AC Marcy, S Mavroukakis, ...",BLOOD 132,,0,2018
GD2-directed chimeric antigen receptor T cells mediate potent antitumor effect and cure in xenograft models of diffuse intrinsic pontine glioma,"RG Majzner, C Mount, S Sundaresh, E Arnold, M Kadapakkam, ...",CANCER RESEARCH 78 (19),,0,2018
Abstract PR04: GD2-directed chimeric antigen receptor T cells mediate potent antitumor effect and cure in xenograft models of diffuse intrinsic pontine glioma,"RG Majzner, C Mount, S Sundaresh, E Arnold, M Kadapakkam, ...","Cancer Research 78 (19 Supplement), PR04-PR04",,0,2018
Abstract LB-111: Precise regulation of CAR signaling prevents and reverses CAR T cell exhaustion,"EW Weber, RC Lynn, M Malipatlolla, E Sotillo, P Xu, CL Mackall","Cancer Research 78 (13 Supplement), LB-111-LB-111",,0,2018
Anti-GD2 chimeric antigen receptor T cells as a potent immunotherapy regimen in xenograft models of histone 3 K27M mutant diffuse midline glioma,"CW Mount, R Majzner, S Sundaresh, EP Arnold, M Kadapakkam, S Haile, ...","Cancer Research 78 (13 Supplement), 958-958",,0,2018
DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA,"C Mount, R Majzner, S Sundaresh, E Arnold, M Kadapakkam, S Haile, ...","Neuro-Oncology 20 (Suppl 2), i56",,0,2018
ATRT-25. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON ATYPICAL RHABDOID TERATOID TUMOR (ATRT) AND IS A PROMISING CANDIDATE FOR CAR T CELL THERAPY,"J Theruvath, CM Graef, S Heitzeneder, R Majzner, S Mitra, SH Cheshier, ...","Neuro-Oncology 20 (Suppl 2), i33",,0,2018
Dual specific anti-cd22-anti-cd19 chimeric antigen receptors,"TJ Fry, CL Mackall, RJ Orentas, H Waleed, H Qin","US Patent App. 15/559,485",,0,2018
Phase II study of epacadostat with pembrolizumab in metastatic or unresectable gastroesophageal junction and gastric adenocarcinoma requiring paired biopsies.,"A Kardosh, D Tseng, B Sahaf, A Zomet, J Krupa, GA Fisher, DS Wang, ...","Journal of Clinical Oncology 36 (4_suppl), TPS191-TPS191",,0,2018
Anti-CD22 chimeric antigen receptors,"RJ Orentas, CL Mackall, IH Pastan","US Patent 9,868,774",,0,2018
"Anti-cd276 polypeptides, proteins, and chimeric antigen receptors","RJ Orentas, Z Zhu, CL Mackall, DS Dimitrov, BS Croix, S Saha","US Patent App. 15/699,419",,0,2017
327 B7-H3 Chimeric Antigen Receptor Modified T Cells Show Potent Anti-Tumor Activity in a Preclinical Model of Glioblastoma,"KH Chow, S Heitzeneder, P Xu, J Theruvath, SS Mitra, SH Cheshier, G Li, ...","Neurosurgery 64 (CN_suppl_1), 272-272",,0,2017
Targeting GPR64 in pediatric sarcomas with CAR transgenic T cells,"D Schirmer, I Storz, K Wisskirchen, R Feederle, O Schmidt, H Abken, ...","Cancer Research 77 (13 Supplement), 3764-3764",,0,2017
GPC2 is an oncogene and immunotherapeutic target in high-risk neuroblastoma,"KR Bosse, P Raman, M Lane, RT Sussman, JL Harenza, D Martinez, ...","Cancer Research 77 (13 Supplement), 685-685",,0,2017
Inhibition of the novel therapeutic target pregnancy associated plasma protein A (PAPP-A) in Ewing sarcoma enhances efficacy of IGF1R targeting in vivo,"S Heitzeneder, JF Shern, LJ Helman, J Khan, CL Mackall","Cancer Research 77 (13 Supplement), 1597-1597",,0,2017
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer,"DW Lee, DM Barrett, C Mackall, R Orentas, SA Grupp","CLINICAL CANCER RESEARCH 23 (2), 611-611",,0,2017
Removal Of Myeloid Cells From Autologous Leukocytes Used For Chimeric Antigen Receptor (Car) T Cell Manufacturing Improves Final Product Consistency And Yields,"D Stroncek, DW Lee, M Sabatino, J Ren, S Highfill, C Mackall",,,0,2017
CeLLuLAR TheRAPy,"NN Shah, DM Loeb, H Khuu, D Stroncek, T Ariyo, M Raffeld, C Delbrook, ...",The BoTTom LiNe 22 (12),,0,2016
USE OF ELTJTRIATED LYMPHOCYTES FOR MANUFACTURING CD19-CHIMERIC ANTIGEN RECEPTOR T CELLS IMPROVES THE QUANTITY OF TRANSDUCED T CELLS IN THE FINAL PRODUCT,"D Stroncek, J Ren, M Sabatino, H Khuu, DW Lee, C Mackall","CYTOTHERAPY 18 (6), S65-S65",,0,2016
"Autologous genetically engineered NY-ESO-1 (c259) T in HLA-A (star) 02: 01, HLA (star) 02: 05 and HLA (star) 02: 06 positive patients with NY-ESO-1 expressing tumors","C Mackall, SP D'Angelo, SA Grupp, K Odunsi, MC Cristea, GP Linette, ...",JOURNAL OF CLINICAL ONCOLOGY 34 (15),,0,2016
192. Deep Phenotyping of Manufactured Enhanced-Affinity NY-ESO-1-Specific T Cells Reveals a Pattern of Effector and Memory Programming That Correlates with Clinical Outcome in …,"L Melchiori, DE Lowther, GK Binder-Scholl, DD Williams, Y Peretz, ...","Molecular Therapy 24, S75",,0,2016
Abstract PR02: GPC2 is a candidate immunotherapeutic target and putative oncogene in high-risk neuroblastoma and other pediatric cancers,"KR Bosse, P Raman, RT Sussman, M Randall, D Martinez, Z Zhu, ...","Cancer Research 76 (5 Supplement), PR02-PR02",,0,2016
Evaluation of attenuated HSV1716 in combination with chimeric antigen receptor T cells for solid tumors,"S Haile, J Conner, C Mackall",Cancer Immunology Research 4 (1),,0,2016
Latest in Clinical Application of CAR Cell Therapy for B-cell Malignancy and Transplantation,CL Mackall,"Blood 126 (23), SCI-24-SCI-24",,0,2015
Antigen-induced downmodulation is associated with diminished efficacy of a novel chimeric antigen receptor targeting anaplastic lymphoma kinase,"AJ Walker, L Zhang, AH Long, RJ Orentas, CL Mackall","Cancer Research 75 (15 Supplement), 3140-3140",,0,2015
Restricting aerobic glycolysis provides functional improvement of chimeric antigen receptor (CAR)-modified T cells,"JP Smith, AH Long, CL Mackall","Cancer Research 75 (15 Supplement), 3141-3141",,0,2015
Hematopoietic stem cell niche activation and progenitor mobilization mediate cancer-associated immunosuppression and metastasis,"AJ Giles, M Murgai, Y Vicioso, S Highfill, M Kasai, L Vahdat, L Wexler, ...","Cancer Research 75 (15 Supplement), 4725-4725",,0,2015
T cells engineered to express a chimeric antigen receptor targeting chondroitin sulfate proteoglycan 4 (CSPG4) specifically kill medulloblastoma and produce inflammatory cytokines,"CM Rota, N Tschernia, S Feldman, C Mackall, DW Lee","Cancer Research 75 (15 Supplement), 3151-3151",,0,2015
FGFR4 as a potential therapeutic target for monoclonal antibody based intervention in rhabdomyosarcoma,"S Baskar, N Shivaprasad, Z Zhu, D Dimitrov, M Sigrist, P Sorensen, ...","Cancer Research 75 (15 Supplement), 2488-2488",,0,2015
Preferential expression of CD99 isoform variant 5 (CD99v005) in Ewing sarcoma compared to normal tissues,"S Heitzeneder, JF Shern, J Khan, CL Mackall","Cancer Research 75 (15 Supplement), 1357-1357",,0,2015
511. Enhanced-Affinity NY-ESO-1-Specific T Cells Exhibit Extended Functionality without Exhaustion in a Pattern of Effector and Memory Programming in Multiple Cancer Indications,"L Melchiori, DD Williams, GK Binder-Scholl, R Wong, M Kreutz, ...","Molecular Therapy 23, S204-S205",,0,2015
Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia,"NN Shah, B Yates, C Delbrook, DW Lee, T Fleisher, S Rampertaap, ...","Biology of Blood and Marrow Transplantation 21 (2), S309",,0,2015
"Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)","A Walker, P Lopomo, W Babbitt, M Vigny, C Mackall, R Orentas","Journal for immunotherapy of cancer 2 (3), P40",,0,2014
Metastasis prevention using fibroblast activation protein-targeting prodrugs at the pre-metastatic niche,"M Murgai, A Giles, M Kasai, Y Vicioso, C Mackall, R Kaplan","Cancer Research 74 (19 Supplement), 2074-2074",,0,2014
"Adoptive immunotherapy for pediatric solid tumors with CAR-T cells (chimeric antigen receptor bearing T cells) targeting ALK (anaplastic lymphoma kinase, CD246)","A Walker, P Lopomo, W Babbitt, M Vigny, CL Mackall, RJ Orentas","Cancer Research 74 (19 Supplement), 2799-2799",,0,2014
Development and characterization of anti-FGFR4 monoclonal antibodies as therapeutic agents for human rhabdomyosarcoma,"S Baskar, Z Zhu, RL Labitigan, M Ovanesian, RJ Orentas, SQ Li, ...","Cancer Research 74 (19 Supplement), 652-652",,0,2014
Bone marrow hematopoietic stem cell niche activation and mobilization fosters the metastatic niche,"AJ Giles, M Murgai, Y Vicioso, S Highfil, C Mackall, L Wexler, D Lyden, ...","Cancer Research 74 (19 Supplement), 3058-3058",,0,2014
"14g2a-based GD2-specific chimeric antigen receptors (CARs) constitutively signal, leading to rapidly induced T-cell exhaustion and poor antitumor efficacy in vivo","A Long, RJ Orentas, CL Mackall","Cancer Research 74 (19 Supplement), 2943-2943",,0,2014
Metastatic melanoma presenting during childhood: NCI Pediatric Oncology Branch experience.,"MS Merchant, DB Bernstein, C Delbrook, M Wright, C Mackall","Journal of Clinical Oncology 32 (15_suppl), 10075-10075",,0,2014
Introduction to the series of reviews on “Antibody Derivatives as New Therapeutics for Hematologic Malignancies”,CL Mackall,"Blood 123 (15), 2283-2284",,0,2014
Immunogenic peptides and methods of use for treating and preventing cancer,"JA Berzofsky, LT Van Den Broeke, C MacKall, LJ Helman","US Patent 8,614,304",,0,2013
The T Cell Receptor As An Oncogene: Thymic Expression Of Self-Reactive T Cell Receptors Targeting Survivin Induces T-Cell Lymphoblastic Leukmia,"Y Cui, M Onozawa, L Samsel, H Garber, H Zhang, H Qin, TJ Fry, ...","Blood, The Journal of the American Society of Hematology 122 (21), 167-167",,0,2013
LANGERHANS CELLS IN THE TGFB1 NULL,"TA Borkowski, JJ Letterio, CL Mackall, A Saitoh, EI Branch","Dendritic Cells in Fundamental and Clinical Immunology 3, 307",,0,2013
"ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors","RJ Orentas, P Lopomo, W Babbitt, M Vigny, CL Mackall","Journal for immunotherapy of cancer 1 (Suppl 1), P27",,0,2013
Enhanced glycolytic metabolism is associated with exhaustion and poor antitumor efficacy in a xenograft model of chimeric antigen receptor T cell therapy for sarcoma,"AH Long, RJ Orentas, CL Mackall","Journal for immunotherapy of cancer 1 (1), P21",,0,2013
"Q&A: Crystal Mackall, John Maris on pediatrics.","C Mackall, J Maris","Cancer discovery 3 (9), 961-961",,0,2013
Targeting B Cell Precursor Acute Lymphoblastic Leukemia (ALL) with Chimeric Antigen Receptors (CARs) Specific for CD19 or CD22,"RJ Orentas, W Haso, DW Lee, TJ Fry, AS Wayne, CL Mackall","MOLECULAR THERAPY 21, S125-S125",,0,2013
Connect with NCI Public Affairs,"S McNeil, A Budhu, NCI Grantees, AS Rabson, H Kong, H Varmus, ...",Imaging,,0,2013
Evaluation of lymphoid organs by FDG PET/CT in high risk sarcoma patients receiving immunotherapy (IT) with tumor vaccine compared with tumor vaccine and IL-7,"C Millo, G Khorjekar, M Merchant, C Sioka, C Mackall","Journal of Nuclear Medicine 54 (supplement 2), 603-603",,0,2013
T cell lymphoblastic leukemia in survivin TCR transgenic mice.,"Y Cui, M Onozawa, H Qin, T Fry, P Aplan, CL Mackall","Cancer Research 73 (8 Supplement), 3309-3309",,0,2013
Tumor-induced fibrocytes mediate immune suppression via Indoleamine Oxidase.,"H Zhang, CL Mackall","Cancer Research 73 (8 Supplement), 466-466",,0,2013
Evaluating the susceptibility of solid tumors to chimeric antigen receptor modified T cell therapies.,"AH Long, SL Highfill, WM Haso, RJ Orentas, CL Mackall","Cancer Research 73 (8 Supplement), 3974-3974",,0,2013
Interleukin-7 Worsens Graft-vs-Host Disease,"ML Sinha, TJ Fry, DH Fowler, G Miller, CL Mackall, PO Branch",,,0,2013
A New High Activity Anti-CD22 Chimeric Antigen Receptor (CAR) Targeting B Cell Leukemia.,"W Haso, DW Lee, I Pastan, DS Dimitrov, CL Mackall, RJ Orentas","Blood 120 (21), 2611-2611",,0,2012
Illegitimate V (D) J Recombination Involving Notch1 and Bcl11b in Precursor T-Cell Lymphoblastic Leukemia/Lymphoma,"M Onozawa, H Kim, SM Gough, Y Lin, Y Cui, SH Beachy, CL Mackall, ...","Blood 120 (21), 1323-1323",,0,2012
Targeting CD22 Expressing B Cell Leukemia With Chimeric Antigen Receptors (CAR): Engineering Membrane Proximity and Second Signaling Motifs for Optimal Activity,"W Haso, DW Lee, IH Pastan, DS Dimitrov, D Fitzgerald, CL Mackall, ...","JOURNAL OF IMMUNOTHERAPY 35 (9), 723-723",,0,2012
Overcoming Tumor-induced Negative Regulatory Pathways in Murine Models of Rhabdomyosarcoma,"SL Highfill, CL Mackall","JOURNAL OF IMMUNOTHERAPY 35 (9), 776-777",,0,2012
Soluble IL7Ra isoform modulates IL7 signalling and homeostasis: P100,"W Lundström, S Walsh, S Beq, J Hillert, C Mackall",Cytokine 59 (3),,0,2012
TCR triggering controls IL7 responsiveness and homeostatic expansion of CD4+ T cells during IL7 therapy: P0740,"D Leboeuf, O Hennion-Tscheltzoff, S Gauthier, C Mackall, M Guimond",Immunology 137,,0,2012
P100 Soluble IL7Ra isoform modulates IL7 signalling and homeostasis,"W Lundström, S Walsh, S Beq, J Hillert, C Mackall","Cytokine 59 (3), 551",,0,2012
Short-term cytolytic assays are not predictive of chimeric antigen receptor anti-tumor activity mediated by some T cell subsets,"TL Lin, DW Lee, JN Kochenderfer, CL Mackall","Cancer Research 72 (8 Supplement), 3502-3502",,0,2012
Generation and optimization of a chimeric antigen receptor against human CD22: A new immunotherapeutic agent for adoptive immunotherapy,"W Haso, D Lee, R Morgan, I Pastan, C Mackall, RJ Orentas","Cancer Research 72 (8 Supplement), 3504-3504",,0,2012
A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell (DC) Vaccination and Donor Lymphocyte Infusion (DLI) for WT1-Expressing Hematologic Malignancies and Post …,"NN Shah, D Loeb, H Khuu, D Stroncek, M Raffeld, C Delbrook, ...","Biology of Blood and Marrow Transplantation 18 (2), S259-S260",,0,2012
Modulation of immune cell niches for therapeutics in cancer and inflammatory diseases,NM Fewkes,University of Oxford,,0,2012
Interleukin 7 signaling on DCs regulates the CD 4 T cell niche,"N Fewkes, C Mackall, F Powrie",,,0,2011
Generation and Optimization of a Chimeric Antigen Receptor Against CD22: A New Immunotherapeutic Agent for Treating B Lineage Leukemia and Lymphoma,"RJ Orentas, W Haso, RA Morgan, I Pastan, CL Mackall","Blood 118 (21), 4313-4313",,0,2011
T Cell Lymphoblastic Lymphoma Resulting From Expression of Self-Reactive TCRs During Early Thymopoiesis,"Y Cui, H Garber, M Onozawa, H Qin, TJ Fry, P Aplan, CL Mackall","Blood 118 (21), 2057-2057",,0,2011
"ALL Xenografts Reveal the Importance of Anti-CD19-Chimeric Antigen Receptor Cell Dose, Cell Persistence and Surprising Antitumor Activity of CD4+ Anti-CD19-CAR T Cells in …","DW Lee, JN Kochenderfer, RJ Orentas, EG Gardner, CL Mackall","Blood 118 (21), 574-574",,0,2011
Pilot immunotherapy trial in high-risk pediatric sarcomas.,"MO Amoako, MS Merchant, DB Bernstein, K Baird, C Mackall","Journal of Clinical Oncology 29 (15_suppl), 9541-9541",,0,2011
Can the well-credentialed neuroblastoma tumor antigen GD2 be exploited for T-cell-based immunotherapy of pediatric sarcomas?,"S Ramakrishna, S Gottschalk, R Morgan, G Dotti, MK Brenner, R Orentas, ...","Journal of Clinical Oncology 29 (15_suppl), 9531-9531",,0,2011
A novel subset of myeloid suppressor cells in pediatric cancer patients (66.9),"H Zhang, S Galli, C Mackall","The Journal of Immunology 186 (1 Supplement), 66.9-66.9",,0,2011
Survivin TCR transgenic mice develop T cell lymphoblastic lymphoma (48.25),"Y Cui, H Garber, C Mackall","The Journal of Immunology 186 (1 Supplement), 48.25-48.25",,0,2011
Genital Graft Versus Host Disease: Acute Versus Early Onset Chronic Disease,"S Lafond, T Klepac Pulanic, M Turner, M Bishop, D Fowler, C Mackall, ...","Biology of Blood and Marrow Transplantation 17 (2), 3",,0,2011
T-cell regeneration after bone marrow transplantation: differential,"CL Mackall, L Granger, MA Sheard, R Cepeda, RE Gress",,,0,2011
Lymphocyte depletion during treatment with intensive chemotherapy,"LL McClure, RE Gress, CL Mackall, TA Fleisher, MR Brown, IT Magrath, ...",,,0,2011
4-1BBL-Expressing aAPCs Attenuate IL-15-Induced NK Cell Expansion and Cytokine Production In Vitro but Induce NK Cell-Mediated Gvhd In Vivo,"CM Capitini, JL Meadors, MM Cho, RJ Orentas, CL Mackall, TJ Fry","Blood 116 (21), 2536-2536",,0,2010
Dipeptidyl Peptidase Inhibition Alters Myeloid Derived Suppressor Cell Phenotype and Induces Regression of Pediatric Sarcomas.,"N Bouchkouj, S Larabee, H Qin, JL Meadors, CL Mackall, TJ Fry","Blood 116 (21), 3792-3792",,0,2010
Novel Antigen-Specific Expansion of T Cells Transduced with a CD19 Chimeric Antigen Receptor,"DW Lee, JN Kochenderfer, C Rader, RJ Orentas, CL Mackall","Blood 116 (21), 3262-3262",,0,2010
Designing a New Chimeric Antigen Receptor for the Tumor Antigen ALK,"RJ Oentas, A Wellstein, RA Morgan, CL Mackall","JOURNAL OF IMMUNOTHERAPY 33 (8), 905-905",,0,2010
Mackall and Guimond respond,"CL MacKall, M Guimond","Nature Immunology 11 (7), 548",,0,2010
Reply to “Is IL-7 from dendritic cells essential for the homeostasis of CD4,"CL Mackall, M Guimond","Nature Immunology 11 (7), 548",,0,2010
"CD11c+ CD123+ human myeloid dendritic cells generated using IL4, IL13 and IL3 show characteristics of myeloid derived suppressor cells","JV Edwards, H Zhang, CL Mackall","Cancer Research 70 (8 Supplement), 3818-3818",,0,2010
Whole cell vaccines prevent primary tumor growth and metastases in murine embryonal rhabdomyosarcoma,"JL Meadors, Y Cui, R Poon, H Zhang, NM Fewkes, RJ Orentas, G Merlino, ...","Cancer Research 70 (8 Supplement), 3420-3420",,0,2010
Pediatric sarcomas are infiltrated with myeloid derived suppressive cells,"N Bouchkouj, H Qin, S Galli, J Buckley, JL Meadors, S Larabee, ...","Cancer Research 70 (8 Supplement), 1332-1332",,0,2010
STAT1-deficient bone marrow prevents GVHD by modulating plasmacytoid DCs while preserving vaccine-mediated responses to tumor (145.40),"C Capitini, S Larabee, H Qin, Y Song, J Khan, C Mackall, T Fry","The Journal of Immunology 184 (1 Supplement), 145.40-145.40",,0,2010
Survivin: A Potential Target of Adoptive Immunotherapy for Pediatric Sarcomas (101.19),"Y Cui, H Garber, H Zhang, C Mackall","The Journal of Immunology 184 (1 Supplement), 101.19-101.19",,0,2010
Artificial Antigen Presenting Cells (aAPC) Expanded NK-Mediated Enhanced Lysis of Allogeneic Tumor Cells Regardless of HLA Class I/KIR Mismatch and Its Implication of Use in …,"H Zhang, B Levine, N Voong, AS Wayne, CH June, CL Mackall","Blood 114 (22), 3023-3023",,0,2009
Abstract# 5682: Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin,"X Wan, SY Kim, A Mendoza, J Briggs, C Yeung, H Zhang, C Mackall, ...","Cancer Research 69 (9 Supplement), 5682-5682",,0,2009
"Peripheral NK Cell Activation and Expansion by Artificial Antigen Presenting Cells, 2D11 (41.25)","H Zhang, B Levine, C June, C Mackall","The Journal of Immunology 182 (1 Supplement), 41.25-41.25",,0,2009
Exploiting and Inducing Changes in T-cell Homeostasis for Immune-based Therapy of Pediatric Cancer,"K Cui, M Guimond, CL Mackall","JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 31 (4), 237-237",,0,2009
Disruption of Gamma Interferon Signaling through the STAT1 Pathway Enhances Alloreactivity While Abrogating GvHD,"CM Capitini, SM Larabee, CL Mackall, TJ Fry","Blood 112 (11), 3512-3512",,0,2008
A Highly Efficient Method to Expand CD3,"S Vasu, M Berg, A Lundqvist, M Ramanathan, R Lopez, P McCoy, ...","Blood 112 (11), 3902-3902",,0,2008
"with high-risk pediatric sarcomas. Clinical cancer research: an official journal of the American Association for Cancer Research 14: 4850-4858, No. 15, 1 Aug 2008 801125023",CL Mackall,"Inpharma 1657, 27",,0,2008
Prolonged survival in patients with ultra high-risk pediatric sarcomas following reduced intensity allogeneic peripheral blood stem cell transplantation,"C Mackall, K Baird, C Love, A Wayne, T Fry","Journal of Clinical Oncology 26 (15_suppl), 21000-21000",,0,2008
Recombinant human IL-7 (rhIL-7) preferentially expands CD4+ and CD8+ naïve T cells and enhances T cell receptor (TCR) repertoire diversity,"C Sportes, FT Hakim, SA Memon, H Zhang, MR Brown, TA Fleisher, ...","The FASEB Journal 22 (1_supplement), 1070.6-1070.6",,0,2008
Depletion of CD25+ T cells and IL-7 administration enhanced anti-tumor effects in mice with B16 melanoma,"Y Cui, C Mackall","The FASEB Journal 22 (1_supplement), 1077.15-1077.15",,0,2008
43: Administration of rhIL-7 Increases TCR Repertoire Diversity Through Preferential Expansion of Naive T Cells,"FT Hakim, SA Memon, C Sportes, H Zhang, K Chua, T Fry, J Engel, ...","Biology of Blood and Marrow Transplantation 14 (2), 18",,0,2008
249: Prolonged Survival for Ultra High-Risk Pediatric Sarcoma Patients following Reduced-Intensity Allogeneic Stem Cell Transplantation (AlloSCT),"K Baird, C Love, SM Steinberg, CL Mackall, AS Wayne, TJ Fry","Biology of Blood and Marrow Transplantation 14 (2), 92",,0,2008
Mechanism by which exogenous administration of FIt3 ligand (FL) expands natural killer cells In Vivo,"M Guimond, AG Freud, HC Mao, BW Blaser, GG Lagemann, ...","BLOOD 110 (11), 684A-684A",,0,2007
Loss of IFNγR1 Signaling on Donor Bone Marrow Abrogates GVHD but Maintains Immunocompetence.,"CM Capitini, S Herby, CL Mackall, TJ Fry","Blood 110 (11), 2180-2180",,0,2007
Elevated Serum Interleukin-7 Levels Precede the Development of Acute Graft-Versus-Host Disease.,"RM Dean, T Fry, C Mackall, SM Steinberg, FT Hakim, DH Fowler, J Odom, ...","Blood 110 (11), 1064-1064",,0,2007
Mechanism by Which Exogenous Administration of Flt3 Ligand (FL) Expands Natural Killer Cells ,"M Guimond, AG Freud, HC Mao, BW Blaser, GG Lagemann, ...","Blood 110 (11), 2310-2310",,0,2007
Interleukin-7 Produced by Antigen Presenting Cells Regulates the Homeostatic Peripheral Expansion of Naive CD4 T Cells.,"M Guimond, RG Veenstra, DJ Grindler, Y Cui, R Na, L Hennighausen, ...","Blood 110 (11), 1333-1333",,0,2007
Interleukin-7 therapy in humans: Proof-of-principle,"C Sportes, F Hakim, S Nemon, TJ Fry, K Cui, R Gress, CL Mackall","JOURNAL OF IMMUNOTHERAPY 30 (8), 876-876",,0,2007
PT-100 induces T cell-mediated MB49 tumor regression,"MP Walsh, SY Kim, A Krauss, JP Davis, N Azizz, M Guimond, CL Mackall, ...","JOURNAL OF IMMUNOTHERAPY 30 (8), 865-866",,0,2007
54 INVITED Long-term cancer survivorship issues: Is there a role for CAM?,"P Mansky, K Hoffman, L Gerber, G Chrousos, S Steinberg, C Mackall","EJC Supplements 5 (4), 18",,0,2007
Highlight,"KM Snyder, CL Mackall","PEDIATRIC BLOOD & CANCER 49 (2), 115-116",,0,2007
"Association of serum interleukin-7 and interleukin-15 levels with immune reconstitution (IR), graft-versus-host disease (GVHD), and survival after reduced-intensity allogeneic …","RM Dean, FT Hakim, T Fry, SM Steinberg, M Boyiadzis, DH Fowler, ...","Journal of Clinical Oncology 25 (18_suppl), 7107-7107",,0,2007
Radiographic tumor response in pediatric patients with newly diagnosed localized (LOC) or metastatic (MET) Ewing’s sarcoma (EWS) following neoadjuvant chemotherapy,"MK Chuk, FM Balis, C Mackall, D Hawkins, N Avila, BC Widemann, ...","Journal of Clinical Oncology 25 (18_suppl), 20008-20008",,0,2007
Presentation Time 9: 30 AM Fellow in Training In Vivo Suppression of Metastatic Murine Osteosarcoma,"S Kim, M Walsh, M Guimond, T Fry, C Mackall, J Briggs, C Khanna, ...",Pediatric Blood & Cancer 48 (6),,0,2007
4-1BB is Superior to CD28 Costimulation for Generating Effector CD8+ T Cells for Adoptive Immunotherapy,"H Zhang, K Snyder, M Suhoski, M Maus, V Kapoor, CH June, CL Mackall",JOURNAL OF IMMUNOLOGY 178,,0,2007
4-1BB is Superior to CD28 Costimulation for Generating Effector CD8+ T Cells for Adoptive Immunotherapy (48.12),"K Snyder, M Suhoski, M Maus, V Kapoor, CH June, CL Mackall","The Journal of Immunology 178 (1 Supplement), S76-S77",,0,2007
285: Manifestations of acute and chronic graft-versus-host-disease in reduced-intensity allogeneic stem cell transplantation (RISCT) for pediatric cancer,"K Baird, TJ Fry, C Love, P Layton, A Rager, T Cordoza-Salzman, ...","Biology of Blood and Marrow Transplantation 13 (2), 104",,0,2007
"Cell Injury, Repair, Aging and Apoptosis-Interferon-g Sensitizes Resistant Ewing's Sarcoma Cells to Tumor Necrosis Factor Apoptosis-Inducing Ligand-Induced Apoptosis by Up …","A Lissat, T Vraetz, M Tsokos, R Klein, M Braun, N Koutelia, P Fisch, ...","American Journal of Pathology 170 (6), 1917-1930",,0,2007
Early Recovery of Thymus-Derived Naïve T Cells in Pediatric Patients (pts) Treated with Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NMSCT) for Cancer.,"TJ Fry, AR Rager, F Hakim, C Love, P Layton, D Fowler, MR Bishop, ...","Blood 108 (11), 310-310",,0,2006
Early recovery of thymus-derived naive T cells in pediatric patients (pts) treated with non-myeloablative allogeneic peripheral blood stem cell transplantation (NMSCT) for cancer.,"TJ Fry, AR Roger, F Hakim, C Love, P Layton, D Fowler, MR Bishop, ...","BLOOD 108 (11), 96A-96A",,0,2006
"rhiL7 Administration in Humans Results in Preferential Expansion of Naïve, and Memory Subsets of CD4+ & CD8+ T-Cells","C Sportés, F Hakim, S Memon, H Zhang, K Chua, M Krumlauf, R Babb, ...","Journal of Immunotherapy 29 (6), 641",,0,2006
PA. 022 INTERFERON-γ SENSITIZES RESISTANT EWING'S SARCOMA CELLS TO TRAIL-INDUCED APOPTOSIS BY UP-REGULATION OF CASPASE-8 WITHOUT ALTERING CHEMOSENSITIVITY,"U Kontny, A Lissât, T Vraetz, R Klein, M Romero, N Kutelia, M Tsokos, ...","Pediatric Blood & Cancer 47 (4), 405-406",,0,2006
The sensitivity of TNF-related apoptosis-inducing ligand in neuroblastoma is increased by higher N-myc level but not blocked by BDNF/TrkB activation,"XZ Yang, JH Zhang, J Jaboin, MS Merchant, G Rajpal, CL Mackall, ...",World J Pediatr 2 (3),,0,2006
Metabolic syndrome traits in long-term survivors of pediatric sarcoma at a single institution,"KE Hoffman, J Derdak, D Bernstein, JC Reynolds, SM Steinberg, ...","Journal of Clinical Oncology 24 (18_suppl), 9041-9041",,0,2006
"Effects of rhIL-7 administration in humans on in vivo expansion of naïve, memory and effector subsets of CD4+ & CD8+ T-cells","C Sportes, F Hakim, M Krumlauf, R Babb, T Fleisher, M Brown, J Engel, ...","Journal of Clinical Oncology 24 (18_suppl), 2504-2504",,0,2006
Surface expression of gp96 on tumors and the maturation of tolerogenic dendritic cells,"MS Merchant, H Zhang, K Chua, C Rader, NK Cheung, CL Mackall","Cancer Research 66 (8 Supplement), 745-745",,0,2006
Rapid immune reconstitution and complete donor chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NMSCT) in pediatric patients (PTS) with …,"TJ Fry, A Rager, F Hakim, C Love, P Layton, D Fowler, MR Bishop, ...","Biology of Blood and Marrow Transplantation 12 (2), 80-81",,0,2006
"Study of the protein expression of the matrix metalloproteinase (MMP-1,-2,-3,-9 and-14) in tumors from ewing family and medulloblastoma of children and adolescents","ECC Mateo, RGP Queiroz, CA Scrideli, LG Tone","Pediatric Blood & Cancer 47 (4), 405",,0,2006
22 Promising γ-Chain Cytokines,"TJ Fry, CL Mackall","Immunotherapy of Cancer, 397",,0,2005
Evaluation of the CD8+ Tumor Associated vs. Non-Tumor Associated Immune Repertoire in Cancer Patients Following Induction of Lymphopenia and Following CD3/4-1BB Based Expansion.,"K Snyder, H Zhang, B Vance, CH June, R Vonderheide, C Mackall","Blood 106 (11), 2390-2390",,0,2005
Two Categories of Biologic Effects Induced by IL-7 on Human T Cells.,"TP Krupica, C Feng, CL Mackall, TJ Fry","Blood 106 (11), 3303-3303",,0,2005
Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (SCT) with Pre-Transplant Targeted Immune Depletion Results in Rapid Full Donor Engraftment in Pediatric …,"TJ Fry, T Cardesa-Salzman, F Hakim, C Love, P Layton, R Gress, ...","Blood 106 (11), 3672-3672",,0,2005
Subclinical GVHD Impairs Responses to Dendritic Cell Vaccines Following Allogeneic Transplantation.,"S Herby, M Milliron, C Mackall, T Fry","Blood 106 (11), 571-571",,0,2005
IL7 BUT NOT IL15 AUGMENTS VACCINE-INDUCED CD8+ EFFECTOR T CELLS IN SIVMAC251-INFECTED MACAQUES,"A Hryniewicz, M Moniuszko, M Betts, M Morre, F Villinger, J Cairns, ...","Journal of Medical Primatology 34 (5-6), 352-353",,0,2005
Effectiveness of chemotherapy in non‐rhabdomyosarcoma soft tissue sarcomas—response,"PC Nathan, L Long, D Bernstein, CL Mackall, LJ Helman, M Tsokos, ...","Pediatric Blood & Cancer 45 (2), 228-228",,0,2005
Anti-metastatic activity of interferon gamma in a xenograft model of Ewing’s sarcoma,"MS Merchant, HU Kontny, CL Mackall","Journal of Clinical Oncology 23 (16_suppl), 8532-8532",,0,2005
ANDREA VELARDI,"CL MACKALL, FT HAKIM","Graft vs. Host Disease, 207",,0,2004
Interleukin-7 Over-Expression Regulates T Cell Versus B Cell Lineage Development in the Thymus.,"N El Kassar, PJ Lucas, F Flomerfelt, M Merchant, CV Bare, S Mahmud, ...","Blood 104 (11), 3238-3238",,0,2004
Thromboembolic events (TEE) in children and young adults with sarcoma,"I Paz-Priel, L Long, D Bernstein, CL Mackall, LJ Helman, AS Wayne","Journal of Clinical Oncology 22 (14_suppl), 8524-8524",,0,2004
Rehabilitation assessments of pediatric sarcoma survivors,"PJ Mansky, L Gerber, K Hoffman, E Augustine, U Chaudhry, B Parks, ...","Journal of Clinical Oncology 22 (14_suppl), 8528-8528",,0,2004
Anti-metastatic effects of a TRAIL receptor agonist and interferon gamma in an orthotopic xenograft model of Ewing’s sarcoma,"MS Merchant, M Romero, F Melchionda, M Tsokos, CL Mackall","Cancer Research 64 (7 Supplement), 1076-1076",,0,2004
T cell depleted hosts are uniquely susceptible to tolerance induced by non-professional APCs and mediated by IL-10 producing CD8+ T cells,"TJ Fry, F Melchionda, CL Mackall","Biology of Blood and Marrow Transplantation 10, 23",,0,2004
"Volume 4 Contents Number 1, July 2003","AD Donnenberg, VS Donnenberg, SS Pendse, DM Briscoe, MH Frank, ...","Clinical and Applied Immunology Reviews 4, 453-455",,0,2004
Dose effect of IL-7 on TCR alpha beta and B cell development in the thymus.,"N El Kassar, PJ Lucas, M Merchant, CV Bare, C Mackall, S Mahmud, ...","BLOOD 102 (11), 564A-564A",,0,2003
Thromboembolic events (TEE) in children and young adults with sarcoma.,"I Paz-Priel, L Long, CL Mackall, LJ Helman, AS Wayne","BLOOD 102 (11), 119B-119B",,0,2003
Efficient expansion of human cytolytic CD8+ T cells using anti-CD3/4-1BBL.,"H Zhang, MV Maus, CH June, CL Mackall","BLOOD 102 (11), 528A-529A",,0,2003
Immune depletion prior to non-myeloablative (NM) allogeneic hematopoietic stem cell transplantation (alloSCT) results in rapid full donor engraftment in pediatric patients with …,"A Wayne, D Fowler, T Fry, F Hakim, C Love, D Miller, M Bishop, C Mackall, ...","BLOOD 102 (11), 968A-968A",,0,2003
Treatment strategies for solid tumors and impact on host defenses,"M Merino, CL Mackall","Management of Infection in Oncology Patients, 1",,0,2003
Dendritic cell-based vaccination for HY-specific immune response generation: Modified female DCs versus male DC endogenous expression,"SK Taylor, F Melchionda, TJ Fry, CL Mackall","PEDIATRIC RESEARCH 53 (4), 16A-16A",,0,2003
"Expansion, maturation, and functional characterization of murine dendritic cells for tumor immunotherapy","JC Karl, SK Taylor, TJ Fry, CL Mackall","PEDIATRIC RESEARCH 53 (4), 275A-275A",,0,2003
Advances in Brief-Tumor Biology-Induction of Caspase 8 by Interferon g Renders Some Neuroblastoma (NB) Cells Sensitive to Tumor Necrosis Factor-related Apoptosis-inducing …,"X Yang, MS Merchant, ME Romero, M Tsokos, LH Wexler, U Kontny, ...","Cancer Research 63 (5), 1122-1129",,0,2003
IL7 and IL15 but not IL2 increase Ag specific effector T cells following dendritic cell based vaccination.,"F Melchionda, TJ Fry, CL Mackall","BLOOD 100 (11), 674A-674A",,0,2002
IL-7 as a therapeutic: immunorestorative agent and vaccine adjuvant,"T Fry, G Melchionda, CL Mackall","EUROPEAN JOURNAL OF CANCER 38, S16-S17",,0,2002
Naturally acquired T cell responses prevent metastatic disease in murine osteosarcoma.,"F Melchionda, M Sinha, C Khanna, M Merchant, T Fry, C Mackall","CLINICAL IMMUNOLOGY 103 (3), S92-S92",,0,2002
A weak tumor antigen induces immune priming and not tolerance during progressive tumor growth.,"F Melchionda, T Fry, M McKirdy, C Mackall","CLINICAL IMMUNOLOGY 103 (3), S108-S109",,0,2002
Characterization of the Immune Responses to the Tumor-associated Hy-antigen,"MA McKirdy, TJ Fry, F Melchionda, CL Mackall","YALE JOURNAL OF BIOLOGY AND MEDICINE 75 (3), 158-158",,0,2002
IL-7 expands T cells in non-human primates.,"TJ Fry, SJ Donohue, TT Hecht, J Tomaszewski, S Giardina, CL Mackall","BLOOD 98 (11), 500A-501A",,0,2001
Progressive tumor growth in a model tumor antigen system does not induce immunologic tolerance but appears to induce weak immunity toward tumor antigens.,"TJ Fry, MA McKirdy, F Medeiros, CL Mackall","BLOOD 98 (11), 386A-386A",,0,2001
Tumor-lytic CD28-CD8+ T cells circulate in patients with Ewing's sarcoma and require alternative costimulation via tumor expression of 4-1BBL.,"H Zhang, KS Chua, W Telford, C Khanna, LJ Helman, EK Thomas, ...","BLOOD 98 (11), 41B-41B",,0,2001
"T cell mediated endogenous immune responses are unable to protect against primary tumor growth, but modulate the development of recurrent disease in murine osterosarcoma.","F Melchionda, M Sinha, C Khanna, MS Merchant, TJ Fry, LJ Helman, ...","BLOOD 98 (11), 387A-388A",,0,2001
IL7 worsens graft verses host disease following allogeneic bone marrow transplantation,"M Sinha, CL Mackall","FASEB JOURNAL 15 (5), A749-A749",,0,2001
"CONCISE COMMUNICATIONS-Long-term Virologic and Immunologic Responses in Human Immunodeficiency Virus Type 1-Infected Children Treated with Indinavir, Zidovudine, and Lamivudine","S Jankelevich, BU Mueller, CL Mackall, S Smith, S Zwerski, LV Wood, ...","Journal of Infectious Diseases 183 (7), 1116-1120",,0,2001
SECTION I SYMPOSIUM-Papers Presented at the Combined Meeting of the American and European Musculoskeletal Tumor Societies-The Classic-Targeting Tumor Specific Translocations in …,"C Mackall, J Berzofsky, LJ Helman","Clinical Orthopaedics and Related Research, 25-31",,0,2000
Sensitivity to trail-mediated apoptosis in Ewing's sarcoma.,"HU Kontny, K Hammerle, P Shayan, CL Mackall, M Niemeyer","BLOOD 94 (10), 193B-193B",,0,1999
Semi-quantitative analysis of T cell receptor repertoire diversity.,"BL Christensen, S Jankelevich, ZJ Duan, NL Noel, CL Mackall","BLOOD 94 (10), 435A-435A",,0,1999
Restoration of immune responses in T cell depleted hosts by inhibition of programmed cell death.,"T Fry, B Christensen, C Mackall","BLOOD 92 (10), 721A-721A",,0,1998
Thymic T cell regenerative capacity in aged hosts given young bone marrow is quantitatively reduced but qualitatively intact.,"CL Mackall, J Punt, P Morgan, AG Farr, RE Gress","BLOOD 90 (10), 2374-2374",,0,1997
Simultaneous expression of FAS-ligand and susceptibility to FAS-mediated cell death in Ewings' sarcoma.,"HY Kontny, CL Mackall","BLOOD 90 (10), 266-266",,0,1997
LANGERHANS CELLS IN THE TGFpl NULL MOUSE,"TA Borkowski, JJ Letterio, CL Mackall, A Saitoh, AG Farr, XJ Wang, ...","Dendritic Cells in Fundamental and Clinical Immunology 3, 307",,0,1997
T cell regeneration after chemotherapy: Implications for immunotherapy in the setting of minimal residual disease,"CL Mackall, FT Hakim, TA Fleisher, MR Brown, DS Dimitrov, RE Gress","European Journal of Cancer 33 (S5), S20-S20",,0,1997
Skewing of the T cell repertoire toward a target antigen during a period of T cell immune reconstitution.,"CL Mackall, RE Gress","PEDIATRIC RESEARCH 39 (4), 935-935",,0,1996
Impaired immune reconstitution post sequential high-dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.,"DT Stein, CL Mackall, CV Bare, MR Brown, CS Carter, N Casey, MY Yu, ...","PEDIATRIC RESEARCH 39 (4), 962-962",,0,1996
SKEWING OF THE T CELL REPERTOIRE TOWARD A TARGET ANTIGEN DURING A PERIOD OF T CELL IMMUNE RECONSTITUTION. ,"CL Mackall, RE Gress","Pediatric Research 39 (S4), 158",,0,1996
IMPAIRED IMMUNE RECONSTITUTION POST SEQUENTIAL HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL BLOOD PROGENITOR CELL (PBPC) INFUSION.† 962,"DT Stein, CL Mackall, CV Bare, MR Brown, CS Carter, N Casey, ...","Pediatric Research 39 (S4), 163",,0,1996
Impaired immune reconstitution post sequential high dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.,"D Stein, C Mackall, C Bare, M Brown, C Carter, N Casey, M Yu, T Fleisher, ...","BLOOD 86 (10), 402-402",,0,1995
REGENERATION OF T-CELLS AFTER CHEMOTHERAPY-REPLY,"CL MACKALL, SM STEINBERG, RE GRESS","NEW ENGLAND JOURNAL OF MEDICINE 332 (24), 1652-1652",,0,1995
Workshop on immune reconstitution after BMT,"LG Lum, RP Witherspoon, D Przepiorka, JE Talmadge, F Momin, ...",Bone Marrow Transplantation 15 (SUPPL. 1),,0,1995
CD4+ T-lymphocyte regeneration after chemotherapy.,CL Mackall,"Biomedicine & Pharmacotherapy 6 (49), 311-312",,0,1995
EFFECT OF STROMAL CELL-LAYERS FROM BONE-MARROW OF PATIENTS PRE-CHEMOTHERAPY AND POSTCHEMOTHERAPY ON GROWTH OF NORMAL CD34+ CELLS,"GN SCHWARTZ, MK WARREN, JM SZABO, C MACKALL, F HAKIM, ...","BLOOD 84 (10), A343-A343",,0,1994
T-LYMPHOCYTE DYSREGULATION IN MICE WITH A TGF-BETA-1 NULL MUTATION,"M CHRIST, A KULKARNI, K HINES, N MCCARTNEYFRANCIS, ...","FASEB JOURNAL 8 (5), A750-A750",,0,1994
AGE-DEPENDENT DIFFERENCES IN CD4+ T-CELL REGENERATION ARE ASSOCIATED WITH INCREASED THYMOPOIESIS IN YOUNGER VS OLDER PATIENTS,"CL MACKALL, TA FLEISCHER, MR BROWN, IT MAGRATH, LH WEXLER, ...","BLOOD 82 (10), A243-A243",,0,1993
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NONHUMAN-PRIMATES USING A SUBPOPULATION OF CD34+ CELLS EXPRESSING THY-1,"RE Donahue, SW Kessler, MR Kirby, AGRICOLA, BA, CE DUNBAR, ...","Blood 82 (10), A297-A297",,0,1993
IMMUNE DYSREGULATION IN TGF-BETA-1 KNOCKOUT MICE,"M CHRIST, A KULKARNI, N MCCARTNEYFRANCIS, A GEISER, ...","JOURNAL OF IMMUNOLOGY 150 (8), A172-A172",,0,1993
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy,"JM Lynch, SA Grupp, A Thomas-Tikhonenko, AB Black, G Wu, C Lanauze, ...",,,0,0
DOI-DEPRICATED,"AB Hanker, CD Young, TP Stricker, RS Cook, CL Arteaga","Cancer Research 74, 19",,0,0
Anti-PD1 Therapy for Pediatric Sarcomas,"S Highfill, R Orentas, C Mackall",,,0,0
Immunotherapeutic Targeting,CL Mackall,,,0,0
2006 TANDEM BMT MEETINGS WILL BE FEB. 16–20 IN HAWAII,"J Molldrem, S Riddell, H Levitsky, J Shaughnessy, B Barlogie, J Downing, ...",,,0,0
729 Biomarkers to Discern Transplantation Tolerance after Allogeneic Hematopoietic Cell Transplantation,"MS Cairo, CT Jordan, CC Maley, C Chao, A Melnick, SA Armstrong, ...",,,0,0
Preface xvii,"MJ Coppes, TJ Fry, CL Mackall, AS Wayne, K Baird, M Egeler",,,0,0
Liddy Shriver Sarcoma Initiative,"C Mackall, J Khan",,,0,0
